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The monolayer of human corneal endothelium plays an important role in maintaining corneal 
transparency by regulating stromal hydration through ion transport channels and junctional 
complexes. However, human corneal endothelial cells are non-proliferative in vivo, leading to 
age-related gradual decrease in cell density. The loss of corneal endothelial cells results in 
enlargement and spreading of the remaining cells to cover the defective area. Despite the 
eventual reduction in cell density, corneal endothelium normally has enough reserve to 
sustain its function throughout an individual’s lifetime. However, accelerated cell loss due to 
ocular surgical trauma and inherited diseases may lead to functional decompensation with 
consequences of corneal edema, reduced corneal clarity, and loss of visual acuity. Currently, 
corneal transplants are still the main treatment option to restore endothelial function. As there 
is a shortage of transplant-grade donor cornea, there is a great demand for tissue-engineered 
corneal endothelium. To induce favorable cellular behaviors, efforts are directed to produce 
scaffolds that recapitulate native cell extracellular matrix environment. We hypothesized that 
topographical cue can differently regulate and improve human corneal endothelial cell 
morphometry and phenotype when different biochemical cues were used. The topographies 
that we tested were nanopillars, microwells, and micropillars patterned onto 
polydimethylsiloxane (PDMS) and tissue culture polystyrene (TCPS). The biochemical cues 
were extracellular matrix (ECM) protein coatings of fibronectin-collagen I (FC), FNC 





-ATPase and zonula occludens-1 (ZO-1) gene and protein expression were studied 
using human corneal endothelial cell B4G12 (HCEC-B4G12). Cellular morphometry was 
measured 3 days after cells formed confluent monolayer. In overall, on FC-PDMS, 1 µm 
pillar induced better cellular behavior as the cells had the greatest cell circularity, lowest cell 




-ATPase and ZO-1 gene and protein expression. On LC-PDMS, 250 
 v 
 
nm pillar resulted in improved cellular behavior with highest ZO-1 gene and protein 
expression and lowest CV of cell area.  
We continued our studies using primary cells. Observation under phase-contrast microscope 
indicated that the cells had the most optimal HCEC characteristic at day 15 of culture which 





ATPase and ZO-1 as well as cellular morphometry analysis were performed. While cell 
morphometry and phenotype were differently regulated, the cells did not reach confluence in 
any combinations of pattern and protein coating, leading to the conclusion that the current 
experimental set-up may be unsuitable for primary cell cultures and needs to be optimized. 
However, when culture substrate was changed to TCPS, primary cells were able to form 
confluent monolayer at day 15. In addition, cell morphometry and proliferation rate were 
differently regulated. Further studies will confirm how topography coated with ECM protein 
changes and improves morphometry, proliferation, and phenotype of primary cells on TCPS. 
To conclude, cell morphometry and phenotype of HCEC-B4G12 and primary HCEC could 
be regulated by modifying extracellular matrix environment. Engineered environment may 
enable fine-tuning of cellular behavior by modifying in vitro culture condition.  
 vi 
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Chapter 1 – Introduction 
1. 1. Anatomy and Physiology of the Human Cornea  
1. 1. 1. Macroscopic Anatomy and Physiology 
  
Figure 1. 1. Cross-sectional anatomy of the eye and the cornea. The corneal epithelium (E) forms the anterior-most 
layer of the cornea, followed by Bowman’s layer (Bw), the corneal stroma (St), Descemet’s membrane (De), and the 
corneal endothelium (En). Eyes and Eyesight, 2009. Klyce, S.D., 1988. 
The human cornea is an avascular transparent tissue that is in contact with the external 
environment. It is also one of the most heavily innervated and sensitive tissues in the body. 
The cornea has thickness of approximately 0.5 mm at the center and 0.7 mm at the periphery 
and measures about 11 mm horizontally and 10 mm vertically. The anterior surface of the 
cornea is convex and aspheric. The curvature is not constant, being the largest at the center 
and smallest at the periphery [1].  
Although the cornea is avascular, it is supplied with blood components by both internal and 
external carotid arteries. These blood-derived factors play important roles in corneal 
metabolism and wound healing. The cells of the corneal epithelium and endothelium are 
metabolically active and require adenosine triphosphate (ATP) generated by glycolysis under 
aerobic conditions as energy source for cellular activities. Glucose is supplied from the 
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aqueous humor while oxygen is mainly obtained from diffusion from tear fluid which absorbs 
oxygen in the air. The remaining small proportion of oxygen is obtained by diffusion from 
limbal circulation and the aqueous humor [1].  
The sensory nerves of the cornea are mostly derived from the ciliary nerves of the ophthalmic 
branch of the trigeminal nerve. They penetrate the cornea radially from the deep peripheral 
stroma and anteriorly to form subepithelial nerve plexus [2]. The nerves are prominent at the 
corneal periphery as their diameter is relatively large. However, they are barely detectable at 
the center. The anterior surface of the cornea is shielded by tear film and the posterior side is 
in contact with the aqueous humor. 
The optical properties of the cornea are attributed by its transparency, contour, surface 
smoothness, and refractive index. The cornea is highly specialized in refracting and 
transmitting light. The total refractive index of the cornea is the sum of refraction at anterior 
and posterior surface as well as the transmission properties of the tissue. The cornea has 
refractive power of 40 to 44 diopters, which accounts to about two thirds of the total 
refractive power of the eye of approximately 60 diopters [1]. The remaining refractive power 
is contributed by the lens of the eye.  
1. 1. 2. Microscopic Anatomy and Physiology  
The cornea consists of three distinct layers: the epithelium, the stroma, and the endothelium. 
Each layer has its own function and is important for the maintenance of corneal structural and 
functional integrity which in turn is crucial for proper physiological functioning of the cornea 
in refraction and biodefense [1].  
1. 1. 2. 1. Corneal Epithelium 
The corneal epithelium is the outermost layer of the cornea forming an impermeable barrier 
to biological and chemical insults from the environment while allowing diffusion of oxygen 
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and solutes. Together with tear film, it maintains an optically smooth corneal surface which is 
important for visual acuity. The corneal epithelium also prevents tear fluid from invading the 
corneal stroma and causing edema. It has a constant thickness of approximately 50 µm over 
its entire surface which is about 10% of the total corneal thickness. The corneal epithelium is 
populated by epidermal ectoderm-derived stratified squamous nonkeratinized epithelial cells. 
The epithelial layer is continuously renewed in response to the normal shedding of the cells 
from the ocular surface [3-4]. 
In performing its physiological function as a barrier to injury and infection, corneal epithelial 
cells are equipped with junctional complexes that prevent passage of substances into the 
deeper layers of the cornea. Tight junctions are found in the superficial cells, gap junctions 
are present in midepithelial cells while adherent junctions and desmosomes are present 
throughout all cell layers of the epithelium. In addition, rapid renewal characteristics of the 
cells helps to protect the cornea from microbial attack and maintain smooth refractive surface 
[1, 4]. Consequently, loss of junctional integrity due to damage to the corneal epithelium can 
lead to breakdown of membrane permeability and selectivity, rendering the cornea vulnerable 
to infection and stromal edema [4].  
1. 1. 2. 2. Corneal Stroma 
The corneal stroma lies between the corneal epithelium and endothelium. It is approximately 
500 µm thick at the center and constitutes about 90% of total thickness of the cornea [5]. The 
stroma is maintained in a relatively deturgesced state with about 78% water content [6]. The 
corneal stroma is comprised of neural crest-derived keratocytes that display long processes 
and are interspersed within lamellae of extracellular matrix. Keratocyte density of 20,000-
24,000 cells/mm
3
 gradually decreases from anterior to posterior stroma [7]. As the principal 
cellular components of the corneal stroma, keratocytes are responsible for producing, 
degrading, and remodeling the stroma and thus are important for wound healing [8]. The 
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components of stromal extracellular matrix are mainly collagen I and V fibers that are 
secreted and maintained by keratocytes. These collagen lamellae are oriented in parallel 
direction to the corneal surface. Proteoglycans and glycosaminoglycans ground substance in 
the stroma influence the arrangement of these fibers [1, 9]. The uniform diameter of the 
fibers, the mean distance between the fibers, and their regular parallel arrangement in layers 
with alternating orthogonal orientations are essential for corneal transparency. This anatomic 
arrangement cancels the scattering of an incident ray by interference from other scattered 
rays, enabling light to be transmitted [1]. As a consequence, when the diameter of and the 
distance between these collagen fibers are heterogeneous due to edema, incident rays become 
randomly scattered and corneal transparency is lost.  
1. 1. 2. 3. Corneal Endothelium  
The cornea endothelium consists of a single layer of cuboidal corneal endothelial cells 
bordering the corneal stroma and the anterior chamber. Lateral sinuous interdigitation of 
junctional complexes among the cells serves as a leaky barrier for bulk fluid flow of the 
aqueous humor to the stroma. Ion transport channels present in the cells constantly pump 
leaked fluid out of the stroma. These two activities together maintain the proper degree of 
hydration of the corneal stroma and consequently prevent stromal edema and loss of visual 
acuity.  
Besides the three layers described above, between the epithelium and the stroma lies 
Bowman’s layer and between the stroma and the endothelium lies Descemet’s membrane. 
Bowman’s layer is composed of collagen fibers randomly interwoven into a dense, felt-like 
sheet. Thus, its structure is distinguished from that of the underlying stroma in which the 
fibers are regularly arranged. Bowman’s layer is about 12 µm thick and does not regenerate 
after injury [1]. The fibers that constitute this layer are comprised primarily of collagen I, III, 
and V. Collagen VII, which is associated with anchoring fibrils of the epithelium, is also 
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present. With average diameter of 20-30 µm, the fibers are one halves to two thirds as thick 
as the fibers of the underlying stroma, which range from 22.5 to 35 µm [1]. The function of 
Bowman’s layer is still unclear although its acellularity has been suggested to act as a 
biological barrier to inhibit posterior infection of viruses that infect the corneal epithelium. 
Nevertheless, there is a lack of significant complications in hundreds of thousands of eyes 
devoid of Bowman’s layer following photorefractive keratectomy, indicating that the layer 
may actually have no critical function [10].  
Descemet’s membrane is a membrane that is continuously secreted throughout life by corneal 
endothelial cells, resulting in age-related increase in thickness. It comprises mostly of 
collagen VIII with collagen IV, collagen XVIII, thrombospondin 1, fibronectin, and tenascin 
constituting the rest of the components [11]. At birth, the membrane is approximately 3 µm 
thick but reaches 5-6 µm at 20 years of age and 13 µm at 80 years of age [8, 12]. The anterior 
part of the membrane has a distinctive banded appearance with banding pattern of 110 nm 
periodicity while the posterior portion, which is secreted after birth, has an amorphous 
ultrastructural texture [8, 13]. The anterior banded zone remains demarcated from the 
posterior non-banded zone and is stable in thickness and appearance throughout life. 
Descemet’s membrane serves as a protective barrier against infection and injuries and is 
readily regenerated.  
1. 2. Overview of the Aqueous Humor  
The aqueous humor is in contact with the apical side of the corneal endothelium. It is a 
transparent and colorless fluid that fills the anterior and posterior chamber of the eye. The 
aqueous humor is secreted by the ciliary epithelium that lines the ciliary processes. It consists 
of albumin as its major constituent after water, with hydrogen peroxide, bicarbonates, lactic 
acid, ascorbic acid, chlorides, glucose, and growth factors constituting the rest of the 
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components [14-15]. Aqueous humor provides nutrition to several ocular components, 
removes waste products of the metabolism, transports neurotransmitters, stabilizes the ocular 
structure, and regulates intraocular pressure and homeostasis of the ocular tissues [16]. In 
pathological conditions, it also allows inflammatory cells and drugs to circulate and distribute 
to different ocular structures.  
Circulating aqueous humor flows around the lens, passing the pupil into the anterior chamber. 
The production of aqueous humor is balanced by its drainage from the eye. Most of the 
outflow occurs through a small collecting duct called Schlemm’s canal which then delivers 
the fluid into the bloodstream via the anterior ciliary veins [17-18].  
1. 3. Origin of the Human Corneal Endothelium  
Formation of the cornea occurs during the last series of major inductive events in eye 
formation. The inductive influence of the lens which is formed at earlier stage stimulates 
alteration in the basal ectodermal cells. These cells undergo increase in height on the basal 
side, upon completion of which, they begin to secrete epithelially-derived collagen I, II, and 
IX to form the primary stroma of the cornea [19].  
The cells of the corneal endothelium derive from the neural crest stem cells which then 
differentiate into mesenchymal cells. One of the evidences pointing to the conclusion of 
neural origin was demonstrated in a study by Hayashi et al. where human corneal endothelial 
cells (HCEC) showed positive immunoreaction against neuronal tissue antigens of neuron-
specific enolase and S-100 protein [20-21]. HCEC also expressed neural cell adhesion 
molecule (N-CAM), cytokeratin, and neurofilaments, which further supports its 
neuroectodermal lineage [22]. At weeks 4-5 of embryonic development, utilizing the primary 
corneal stroma as a basis for migration, the neural crest cells migrate from folds of neural 
ectoderm, over the optic cup, and into the space between the anterior surface of the lens and 
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the surface ectoderm. These cells will later become transformed into the cells of the corneal 
endothelium [19, 23].  
1. 4. Structure and Function of the Human Corneal Endothelium 
The human corneal endothelium lines the most posterior part of the cornea and is comprised 
of a monolayer of HCECs. The cells of the corneal endothelium are mostly hexagonal with 
uniform thickness of 5 µm and width of 20 µm. At birth, the corneal endothelium has 
thickness of approximately 10 µm. Until the age of 3, the individual cells continue to steadily 
flatten until the thickness stabilizes at about 5 µm. This thickness is retained to adulthood. 
Thereafter, decrease in the thickness is gradual but insignificant [24].  
In young adults, the endothelial cell density is about 3,500 cells/mm
2
 with the coefficient of 
variation (CV) of cell area estimated to be about 0.25. From the second to ninth decades of 
life, cell density declines from an average of 3,500 cells/mm
2 
to around 2,300 cells/mm
2 
with 
the density of the central cornea decreasing at a rate of 0.6% per year [25]. Meanwhile, cell 
area increases from 300 µm
2
 to 450 µm
2
, CV increases from 0.25 to 0.29, and the percentage 
of hexagonal cells declines from 75% to 60% [26]. Polymegathism is a term used to describe 
increase in the irregularity of cell area while pleomorphism is defined as deviation in 
hexagonality. The CV of cell area is the most sensitive index to predict corneal endothelial 
dysfunction and hexagonality is an index to signify the progress of endothelial wound 
healing. An increase in cell size and variation in cell shape have been correlated to reduced 




HCEC contains a large nucleus and abundant amount of cytoplasmic organelles including 
mitochondria, Golgi apparatus, endoplasmic reticulum, and free ribosomes. The presence of 
such large numbers of organelles indicates that the cells are metabolically active. At the 




























cotransporters [9]. At the apical side, HCECs form interdigitation between adjacent cells 
which comprises of various junctional complexes, including zonula occludens, macula 
occludens, and macula adherens. At both basolateral and apical sides, glucose transporters are 
present.  
One of the most vital physiological functions of the corneal endothelium is the regulation of 
water content of the corneal stroma and hence maintenance of corneal transparency. The 
swollen stroma has an increased interfibrillar distance as well as disorder of the collagen 
fibrils and proteoglycans ground substance, causing aberrations in light transmission. The 
tendency of the corneal stroma to imbibe water due to its hypertonicity to both the tear film 
and aqueous humor is counterbalanced by the presence of junctional complexes and the 
activity of ion transport systems of the corneal endothelium [27]. The mechanism in which 
the leak of solutes and fluid across the endothelial barrier into the stroma is counterbalanced 
Figure 1. 2. Clinical specular micrographs of corneal 
endothelium of healthy individuals showing age-related 
increase in cell area and shape variability. (A) 20-year-old; (B) 
44-year-old; (C) 59-year-old; (D) 69-year-old; and (E) 83-year-




by active pumping of solutes and passive fluid transfer into the aqueous humor is called 
“pump-leak” [6, 28-29]. Another important function of the corneal endothelium is to allow 
passage of nutrients and oxygen from the aqueous humor to the corneal stroma and 
epithelium and flux of metabolic wastes in the opposite direction.   
Junctional complexes of the corneal endothelium are comprised of tight junctions, adhesion 
junctions, and gap junctions. All these junctions are sensitive to calcium and will breakdown 
if calcium concentration is below threshold. In general, tight junction proteins function to 
regulate paracellular permeability and form apical-basolateral intramembrane diffusion 
barrier that helps to maintain cell-surface polarity. They allow passive selective diffusion of 
ions and small hydrophilic molecules through paracellular pathways. Some tight junction-
associated proteins include zonula occludens 1 (ZO-1) and junction adhesion molecule-A 
(JAM-A) [30-31].  
Adhesion junctions are located basally with respect to tight junctions and function to mediate 
close contact between lateral plasma membranes and the underlying cytoskeleton of 
neighboring cells, resulting in strengthened cell-cell contact. These junctions are comprised 
of several proteins such as cadherins and catenins [30]. As with tight junctions, adhesion 
junction proteins suppress proliferation [32].  
The third type of junctional complexes that form extensive lateral interdigitation between 
neighboring endothelial cells is gap junctions. Gap junctions are localized on the lateral 
membranes basal to the tight junctions with connexin 43 being the major protein expressed 
[30].  
ZO-1 is the first tight junction protein to be identified and one of the most studied 
components of tight junction plaque. It has the typical functional properties and domain 
structure of a scaffolding protein and contains several domains for protein-protein interaction 
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[33]. Besides being associated with assembly of both adherens and tight junctions as well as 
signal transduction, ZO-1 appears to downregulate in proliferative cells, such as found during 
corneal wound repair [32]. The mechanism by which it decreases cell proliferation may 
involve nuclear translocation as ZO-1 has been observed to accumulate transiently in the 
nucleus of proliferating cells. However, its role is still unclear as not all investigators found it 
in the proliferating cell nucleus, suggesting that other factors might affect its nuclear 
localization [34-35].  
The flow of aqueous humor into the corneal stroma is also counteracted by pump proteins 
present in HCECs. An osmotic gradient of sodium (Na
+
) is present between the aqueous 
humor (143 mEq/L) and the stroma (134 mEq/L) which leads to the flux of Na
+
 from the 
aqueous humor and K
+




-ATPase is a plasma membrane 
carrier enzyme expressed in the basolateral membrane of HCECs at a density of 1.5 x 10
6
 
pump sites per cell [36]. It functions to actively pump 2 K
+
 ions into the cells and 3 Na
+
 out 
of the cells, therefore maintaining the osmotic gradient. Coupled with this activity is passive 





-ATPase is an oligomer formed by association of 2 major polypeptides of 
α (catalytic) and β (glycoprotein) subunits. α subunit is responsible for the catalytic and 
transport properties while β subunit is important for regulating normal activity of the enzyme 
[36-37]. Two isoforms of α subunit, namely α1 and α3, are found in HCECs with both of 
them being catalytically competent [36]. The amount of α3 isoforms expressed is less than 
that of α1. Beside Na+/K+-ATPase, bicarbonate-dependent Mg2+-ATPase also plays a critical 
role in the transport of excess fluid back to the aqueous humor. The activity and density of 
pump proteins positively correlate with corneal transparency. 
Carbonic anhydrase, an enzyme found widespread in living organisms, also has a central role 





and flux across the apical membrane. Carbon dioxide diffuses into the cell cytoplasm and 
generates bicarbonate ions (HCO3
-
) in carbonic anhydrase-catalyzed reaction with water. The 




 from the stroma to the aqueous humor as a consequence of the 
pump activity is followed by movement of water in the same direction, thus counteracting the 
swelling tendency of the stroma [38-39]. 
 





. The movement of net negative charge creates a small potential difference (0.5 mV, apical side 
negative) that attracts Na
+
 through the paracellular pathway and across the tight junction (TJ). Bonanno, 2012. 
The low resistance of the corneal endothelium to solutes and fluid flow is a direct 
consequence of its discontinuous tight junctions. While it is unclear why the corneal 
endothelium is so leaky, its high permeability and back-leak of ions is compensated by the 
high metabolic rate of the cells to generate a net flux of ions [40]. In fact, the corneal 
endothelium consumes more than twice amount of oxygen per unit volume as the corneal 
epithelium [41]. In addition, the density of mitochondria in HCEC is second only to 
photoreceptor inner segments [2].  
1. 5. Proliferative State of Human Corneal Endothelial Cells  
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The cell cycle is an orderly sequence of events divided into phases, namely G1, S, G2, and M 
phase. During G0-phase, cells are quiescent with low synthesis of cell-cycle dependent 
proteins and with DNA present in unduplicated (2N) form. Entry of cells from quiescent state 
to G1-phase is induced by the expression of early genes such as c-fos, c-jun, and c-myc as 
well as regulatory proteins termed cyclins. The specific temporal order of cyclin synthesis 
can be used as marker for the stage of the cell cycle. Cyclins D and E are synthesized at the 
early and late G1-phase, respectively, while cyclin A is observed during late G1/S-phase. 
Cyclin E promotes assembly of replication complex by teaming with cell division cycle 6 
(CDC6) to prepare G1-phase nuclei to replicate [42]. Cyclin A helps in the activation of DNA 
synthesis by replication complexes that have already been assembled and inhibits the 
assembly of new ones [42]. In doing so, cyclin A ensures that the assembly phase occuring at 
G1-phase ends before DNA synthesis during S-phase begins and thus preventing re-initiation 
until the next cell cycle. At the exit of S-phase, cyclin B is synthesized. Cyclin B1 assists in 
chromosome condensation, microtubules reorganization, as well as nuclear lamina and Golgi 
apparatus disassembly [43]. For the M-phase to advance to completion, cyclin A and B have 
to be degraded during metaphase and anaphase, respectively.  
The cells of the corneal endothelium are arrested at different points within G1-phase of the 
cell cycle and therefore do not proliferate in vivo. This conclusion comes after a study by 
Joyce et al. which signifies that HCECs expressed cell cycle-associated proteins of cyclin D, 
E, and A while lacking the expression of Ki67, which is the marker for actively cycling cells. 
Cyclin D and E in HCECs are found in the cytoplasm while cyclin A is localized in the 
nucleus. The explanation for the presence of cyclin D and E in the cytoplasm instead of the 
nucleus is that they were reserved for specific triggering mechanism that will move them into 
the nucleus, thus allowing proliferation response to appropriate stimulation. HCECs also 
expressed kinases p33cdk2 and p34cdc2, which are protein kinases active predominantly in 
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the G1-phase and G2/M-phase of the cell cycle, respectively. These kinases, however, are not 
cycle dependent [44].  
As a consequence of lack of proliferative activity, HCEC cell count decreases with age. The 
cell density can be as high as 7000 cells/mm
2
 at birth and this number subsequently reduces. 
During adolescence, the number is down to 3500 cells/mm
2
. The endothelium undergoes a 
mean decrease of 0.6% a year in its cell number after adulthood with large individual 
differences. The loss of HCEC leads to enlargement and spreading of the remaining 
neighboring cells to cover the defective area.  Despite the gradual loss of the cell density, the 
corneal endothelium is normally able to maintain its function throughout an individual’s 
lifetime. This indicates that the endothelium has large functional reserve with molecular basis 
residing in the adaptive capacity of the endothelial pump. However, excessive cell loss, such 
as caused by inflammatory reactions and intraocular surgical trauma, may give rise to 
functional decompensation and subsequent loss of corneal clarity due to stromal or epithelial 
edema. A minimum numerical density of 400-500 cells/mm
2
 is needed to sustain the function 
of the endothelium [30]. 
In contrary to the lack of proliferation in vivo, HCECs have been shown to proliferate in 
vitro, indicating that there may be factors in aqueous humor or other constituents of their 
native environment that inhibit proliferation to occur in situ. In fact, a study by Joyce et al. 
indicated that when transfected with viral oncoproteins such as simian virus 40 (SV40) large 
T antigen and human papilloma virus E6/E7 which induce overcoming of G1-phase arrest in 
many cell types, HCECs expressed relatively abundant amount of Ki67, signifying the ability 
of the cells to proliferate. In addition, in another study by Senoo et al. using organ-cultured 
human donor corneas, it is reported that ethylenediaminetetraacetic acid, widely known as 
EDTA, could promote proliferation with the help of mitogens by disrupting junctional 
integrity as it chelates calcium and deprives the cells from the ions. The finding led to 
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conclusion that the establishment of cell-cell contacts is also inhibitory to HCEC proliferation 
in vitro and is responsible to a large extent for lack of proliferation in vivo [45]. Eventual loss 
of mitotic capacity of HCEC with age has also been shown by the finding that cells from 
younger donors divide more easily in culture than those from older donors [46-48].  
1. 6. Cornea Endothelial Dysfunction  
There are a number of ocular diseases that target the corneal endothelium such as Fuchs’ 
dystrophy, posterior polymorphous corneal dystrophy (PPMD), and endotheliitis [49]. Fuchs’ 
dystrophy is an inherited or acquired disease in which HCECs gradually start to die off. In 
early stages of Fuchs’ dystrophy, growth of cornea guttata progresses from the center of the 
cornea to the periphery. Pump activity of the corneal endothelium is increased despite an 
eventual deterioration in cell density caused by increasing number of guttate lesions. 
However, in end stages when pump sites are significantly reduced, the activity can no longer 
compensate for water influx, resulting in corneal edema. In PPMD, the corneal endothelial 
cells are replaced with cells having epithelial attributes. Instead of an endothelial monolayer, 
the posterior cornea is occupied by variable numbers of stratified squamous epithelial cells 
that show strong expression for a wide variety of cytokeratines (intermediate filament-
forming proteins occurring in epithelial cells) with predominant expression of cytokeratin 7 
and cytokeratin 19 [50]. Endotheliitis due to herpes simplex virus infection of the cornea in 
disciform keratitis results in reduction of pump density which subsequently leads to edema 
[51-52]. 
Apart from diseases that directly affect the corneal endothelium, dysfunction can also be a 
consequence of inflammation, trauma, and other ocular diseases. Cataract surgery, for 
example, could lead to endothelial dysfunction in a condition called pseudophakic bullous 
keratopathy as a result of direct contact to the endothelium via surgical instruments, 
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turbulence from irrigating solutions, and phacoemulsification probe [53]. Keratonocus, which 
is characterized by stromal thinning and corneal conical deformity, results in pleomorphism, 
polymegathism, and degeneration of corneal endothelial cells due to secondary effects of 
mechanical stresses [54-55].  
1. 7. Cornea Transplantation  
The first successful human corneal transplantation was performed more than one hundred 
years ago. Since then, advances in surgical techniques, instrumentation, pharmacology, and 
understanding of the physiology and immunology of the eye have improved the success of 
transplantation. Penetrating keratoplasty (PK), in which the whole cornea is replaced by 
donor tissue, has been the predominant form of corneal transplantation over the past 50 years 
[56].  
Corneal endothelial dysfunction is the leading cause of corneal visual loss and accounts for 
almost one halves of total corneal transplantations in UK [57-58]. The two most common 
causes of corneal transplants are Fuchs’ dystrophy and pseudophakic bullous keratopathy, 
with each of them contributing to one fifths of total cases [57]. Until recently, PK has been 
the only reliable method for treatment of endothelial decompensation. Even though the 
procedure yields optically clear corneas, the refractive results are poor and visual recovery is 
slow. It is also associated with inherent problems pertaining to sutures and wound healing. As 
PK is an ‘open sky’ procedure, it carries an increased risk of suprachoroidal or expulsive 
hemorrhage. In addition, long-term graft survival rates after PK surgery are poor primarily 
due to two causes, namely immunologic graft rejection and continual attrition of donor 
endothelial cells which eventually leads to graft failure [59].  
The advancement in surgical techniques has brought the possibility to explore other forms of 
corneal transplantation. The main focus of these techniques is to minimize unnecessary 
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replacement of healthy unaffected corneal layers by selectively replacing only the diseased 
layers since a significant proportion of corneal diseases involves only either the anterior 
corneal layers or the endothelial cell layer. As such, anterior lamellar keratoplasty (ALK) is a 
procedure of choice for anterior layer replacement while endothelial keratoplasty (EK) is the 
favored procedure for replacement of endothelial layer [56].  
EK is a rapidly emerging lamellar grafting technique that replaces only dysfunctional 
endothelium. It involves a small incision of 4-5 mm, is sutureless, and provides faster visual 
recovery. As EK is a ‘closed eye’ procedure, the risk of hemorrhage is also reduced. EK has a 
lower incidence of graft failure than PK. It rapidly replaces PK and accounts for over 85% of 
transplantations performed for corneal endothelial treatment and represents one thirds of total 
corneal transplant surgery in the US [56, 58]. The concept of EK has been rapidly evolving. 
Melles et al. in 1998 was the first to describe the surgical technique of posterior lamellar 
keratoplasty (PLK) which was further evolved into Descemet’s stripping endothelial 
keratoplasty (DSEK). In DSEK, unhealthy Descemet’s membrane and the endothelium are 
stripped away from the recipient through a peripheral incision and replaced with thin 
manually-dissected lenticule containing posterior stroma, Descemet’s membrane, and the 
endothelium from the donor. This donor button is folded once and then inserted into the 
anterior chamber. The attachment of the donor button to the recipient posterior corneal 
surface is achieved with the use of air bubble in the anterior chamber that holds the graft in 




-ATPase of the donor endothelium adheres the graft to 
the host. Descemet’s stripping automated endothelial keratoplasty (DSAEK) is similar to 
DSEK but involves the use of automated microkeratome dissection to obtain posterior donor 
lamella. The newest concept of EK, namely Descemet’s membrane endothelial keratoplasty 
(DMEK), involves replacement with only Descemet’s membrane and the endothelium of the 
donor [60-61]. Surgical challenges with DMEK are considerable due to the manual precision 
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needed in stripping away only Descemet’s membrane and the endothelium. In addition, the 
immediate tight scrolling-up of the two layers results in high corneal endothelial cell loss and 
dislocation rate. However, DMEK excludes donor corneal stroma which suggests that a 
myopic shift will not occur. In addition, it eliminates the need of microkeratome which eases 
the adoption of the technique, particularly in developing countries where the instrument is 
unavailable [60].  
Corneal transplants require donor corneas. However, shortage of transplant-grade donor 
cornea has been an issue for decades [62-63]. Consequently, restoration of eyesight is 
delayed due to the waiting time before cornea is available. To solve this problem, Heindl et 
al. introduce a novel strategy to maximize the availability of donor corneal tissue by 
combining deep anterior lamellar keratoplasty (DALK) and DMEK. It is performed by 
splitting a single donor cornea into an anterior part (epithelium, Bowman’s layer, and stroma) 
and a posterior part (Descemet’s membrane and endothelium) [64]. The anterior part is used 
for DALK procedure that addresses corneal anterior-stroma disorders of a patient while the 
posterior part is used for DMEK to another patient, reducing the need of donor cornea by 
around 50%. Short-term follow-up of 6 months revealed good visual and refractive outcomes 
with acceptable cell loss while long-term assessment is still ongoing and will be needed to 
access the efficacy of the procedure.  
1. 8. Development of Tissue-Engineered Corneal Endothelium  
The limited availability of transplant-grade corneal tissue motivates the research into 
alternative means of repairing damaged corneal endothelium. Besides split-cornea 
transplantation method as elaborated in the previous section, attempts are also directed to 
produce tissue-engineered corneal endothelium as donor cornea substitute. While artificial 
corneas in the market, such as Boston Keratoprosthesis (KPro) and AlphaCor™, replace the 
 18 
 
whole damaged cornea, tissue-engineered corneal endothelium will enable replacement of 
only the damaged endothelium and thus keep the other healthy layers intact. In the past years, 
there have been numerous studies on development of the tissue-engineered construct with 
variable success. Materials tested as culture substrate and carrier of HCEC sheets vary widely 
and range from naturally-derived (such as collagen and silk) [65-66] to synthetic (including 
poly(N-isopropylacrylamide) and poly(vinyl methyl ether)) [67-68]. Some of the studies are 
discussed below. 
Sumide et al. expanded HCECs obtained from the periphery of donor corneas on type IV 
collagen-coated dishes for five passages [68]. The cells were then plated onto 
thermoresponsive poly(N-isopropylacrylamide) (PNIPAAm) dishes and harvested after 4 
weeks to be transplanted to rabbit corneas devoid of Descemet’s membrane and endothelium. 
Observations up to 7 days post-transplant indicated significant edema reduction and 
transparency improvement.  
Slightly different from the just-mentioned study, Lai et al. cultivated adult HCECs derived 
from eye bank corneas on PNIPAAm-grafted surfaces for 3 weeks, detached the cells from 
the polymer, and transplanted the cell sheet to rabbit corneas denuded of endothelium using 
gelatin hydrogel disc as bioadhesive supporter [66]. Clinical observations and histological 
examinations performed up to 6 months demonstrated that the cell sheets successfully 
integrated into the denuded corneas and exerted pump function as evidenced by recovery and 
maintenance of clarity and thickness of the corneas.  
In a research by Ishino et al., amniotic membrane was used as carrier of cultivated HCEC 
sheets [69]. The graft was transplanted onto rabbit corneas denuded of Descemet’s membrane 
and endothelium. The corneal appearance and thickness were examined daily for 7 days post-
surgery. The transplanted corneas were observed to have little edema and retain their thinness 
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and transparency. Transplanted HCEC density was reduced by 27%, suggesting that the cells 
may be short-lived. In only one of the transplanted corneas, the maintenance of thickness and 
transparency continued for 4 weeks post-transplant.  
Honda et al. seeded cultured HCECs onto human corneal stromal discs and transplanted the 
grafts into rabbits [70]. Observations up to 28 days indicated gradual recovery of corneal 
transparency with donor HCECs covering the posterior surface of the graft.  
In another study by Choi et al., a donor corneal stroma was sliced into 3-4 thin layers, 
decellularized, and seeded with HCECs to generate a tissue-engineered cornea [71]. The 
resulting constructs were incubated in growth medium for 14 days and then analyzed. The 




-ATPase and ZO-1 functional markers and the construct had 
mechanical properties similar to those of normal corneas.  
The studies cited above demonstrate the numerous potential ways in which tissue-engineered 
corneal endothelium can be constructed. Although promising, in all these studies, the longest 
follow-up was only 6 months with long-term performance and consequence of the tissue-
engineered constructs unknown. Thus, further research is needed to ascertain the feasibility of 
the engineered grafts for use in clinical applications. In addition, in vivo studies were 
performed on rabbit corneas which have proliferative corneal endothelial cells; therefore, the 
results may not be representative of human corneas.  
1. 9. In Vitro Culture of Clonal Cell Line HCEC-B4G12  
Cell lines are appropriate model systems for use in basic cell biology and method 
development research for cellular applications in regenerative therapies. The use of cell lines 
avoids the problems posed by donor-to-donor variability which could mask the reliability of 
the data. While previously a corneal endothelial cell line has been established by Bednarz et 
al., the cell population derived from whole corneal endothelium including the periphery and 
 20 
 
centre is heterogeneous and thus represents the entirety of HCEC populations. This 
heterogeneity renders it difficult to precisely characterize cellular features and functions [72]. 
Since studies have shown differences in characteristics of cells from central and peripheral 
region, homogeneous cells are preferred.  
HCEC-B4G12 was obtained by cloning the immortalized adult HCEC population established 
by SV40 transfection by means of electroporation [72]. SV40 large T antigen transfection 
significantly increases the proliferation rate of cells by inducing greater G1 transit rates. The 
transfected cells were adapted to serum-free conditions and the cloned cells were cultured in 
the same condition throughout. Immunocytochemistry indicated that HCEC-B4G12 




-ATPase α1 and α3 [36, 
73]. The cells also expressed abundant amount of collagen IV but no collagen III. In addition, 
they were polygonal, strongly adherent, had smooth cell surface, and formed a distinct 
monolayer. These features led to the conclusion that HCEC-B4G12 represents an ideal model 
of differentiated HCEC [74].  
1. 10. In Vitro Culture of Primary HCEC 
Since a few decades ago, protocols to isolate and cultivate primary HCECs have been 
continually evolving. Isolation of HCECs has evolved from explant culture method to 
scraping method. Currently, the isolation involves a two-step, peel-and-digest method by 
which both Descemet’s membrane and the corneal endothelium are peeled off from the 
cornea and subjected to enzymatic digestion which releases the corneal endothelial cells from 
the Descemet’s membrane [75].  
One of the earliest optimization of in vitro culture systems was presented in a study by 
Engelmann et al. in which 25 different nutrient media, different sera, 6 mitogens, and 
numerous substrates were tested [73]. F99 medium, an equal-ratio mixture of medium M199 
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and Ham’s F12, was found to be the most effective basal medium to promote HCEC clonal 
growth. Fibroblast growth factor (FGF) was essential for growth at low serum concentrations. 
When combined with F99 medium, human serum and fetal bovine serum showed optimal 
growth-promoting effect. However, the two sera are not recommended for growth media as 
HCEC monolayers grown in them were fibroblast-like, indicating that the normal in vivo 
form with its functional and morphological properties was not retained. Other media that 
have been shown to support growth and proliferation of HCEC cultures include Minimum 
Essential Medium (MEM) basal medium supplemented with serum, glutamine, amino acids, 
gentamicin, and amphotericin B [76]; M199 with serum, glutamine, endothelial cell growth 
supplement (ECGS), and antibiotics [77]; Opti-MEM-I with serum, nerve growth factor 
(NGF), epidermal growth factor (EGF), ascorbic acid, calcium chloride, pituitary extract, and 
antibiotics [78]; and Dulbecco’s Modified Eagle Medium (DMEM) containing serum, bFGF, 
and antibiotics [69].  
To enhance HCEC attachment and growth in culture, culture surfaces were coated with 
extracellular matrix (ECM) proteins. Engelmann et al. found that formation of monolayer 
with morphology similar to in vivo corneal endothelium was obtained on culture dishes 
coated with basal membrane components of collagen IV, laminin, or fibronectin [73]. Other 
coatings that have been successfully shown to establish confluent monolayer of primary 
cultures include matrix elaborated by cultured bovine corneal endothelial cells (BCEC) [79-
80], denuded Descemet’s membrane [81], and FNC Coating Mix® [78]. 
Despite the numerous culture systems tested, it is still challenging to establish consistent 
long-term HCEC culture. Primary cultures normally undergo only up to 20 cumulative 
population doublings [82]. Currently, in vitro expansion of primary HCECs can only yield 
cells to a few passages with subsequent passaging resulting in dedifferentiation into 
fibroblast-like cells with loss of HCEC phenotypic markers [83]. This situation denotes the 
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need for further research into successful expansion of primary cultures with maintenance of 
morphological and phenotypic characteristics.  
1. 11. PDMS as Cell Culture Substrate 
PDMS is an elastic and optically transparent organosilicon polymer. It is chemically inert, 
highly permeable to gas, biocompatible, highly oxidative, thermally stable, and has low 
toxicity [84]. For soft lithography, the most commonly used form of PDMS derives from a 
base and a curing agent which undergo hydrosilylation reaction during crosslinking. 
Specifically, Sylgard 184, a product of Dow Corning, consists of a base comprising 
dimethylsiloxane oligomers with vinyl-terminated end groups, platinum catalyst, and silica 
fillers of dimethylvinylated and trimethylated silica and a curing agent with 
dimethylmethylhydrogen siloxane as crosslinking agent and tetramethyltetravinyl 
cyclotetrasiloxane as inhibitor [85]. The suggested ratio of base to curing agent is 10:1 and 
the amount of uncrosslinked groups depends on the curing temperature and time.  
In cell biology research, PDMS has been widely used as cell culture platform [86-87], owing 
to its hemocompatibility and biocompatibility [88]. The extensive use of PDMS for cell 
behavior studies is also owing to its ease of micro- and nano-patterning as well as tuneable 
rigidity by simply varying the ratio of base to curing agent [89-91].  
1. 12. Cell Interaction with Topography 
The three-dimensional structure of tissues and organs of the body is highly complex and 
unique. Each organ that constitutes the body has its own morphological and functional 
characteristics that are indispensable for the proper working of the body systems.  
The proper maintenance of tissue morphogenesis, differentiation, and homeostasis is 
attributed to the ECM environment which provides physical scaffolds as well as biochemical 
and biomechanical cues to its cellular constituents [92-93]. Although these matrices in 
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general contain glycoproteins, collagens, and proteoglycans as their major structural 
elements, the physical, topological, and biochemical composition of ECM is tissue-specific 
and heterogeneous. ECM is also highly dynamic and constantly being remodeled. Cells 
adhere to and sense the ECM environment through ECM receptors, including integrins and 
syndecans. They interact with topographical structures of the ECM mainly through contact 
guidance. The ECM proteins exhibit abundant nanometer-sized structures that contribute to 
cell-matrix signaling by providing the cells with mechanotransductive cues that affect and 
direct basic cell functions including migration, polarization, adhesion, proliferation, and 
apoptosis.  
Given the many roles that substrate topography plays in cellular functions, it has become an 
attractive strategy for application in regenerative medicine. Cell interaction with topography 
can be used as a signaling mechanism to control many aspects of cellular behavior. In order 
to recapitulate native ECM environment, two-dimensional synthetic nano-fabricated 
topographical substrate with structure and length scale of native topography has been 
developed along with advances in micro- and nano-fabrication techniques. Cellular response 
to synthetic topographies depends on the cell type, the size and geometry of the topographical 
feature, as well as the physical properties of the substrate. While topography influences many 
cellular functions [94], one of its most apparent effects is the alteration in cellular geometry 
[95]. This response has been observed in many cell types across different species and is 
usually stronger upon decrease in feature pitch and increase in feature depth. For example, 
when subjected to gratings, many types of cells simultaneously align and elongate in the 
direction of grating axis [96-98]. On nanopost and nanopit features, cells generally have 
reduced spreading. Besides cellular geometry, synthetic topography has been shown to 
regulate cellular proliferation, migration, and gene expression.  
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Topographical cues can also act synergistically with other biochemical and biophysical cues 
to regulate cell functions. For example, combined effects of nanotopography and neuronal 
induction media enhanced differentiation of human mesenchymal stem cells into neuronal 
lineage by up-regulating neuronal markers [99].  
The application of topography in corneal tissue engineering has been reported in literature. In 
a study by Gruschwitz et al., primary and immortalized HCECs seeded onto aligned collagen 
I fibrils were found to align along the direction of fibril orientation [100]. However, it is 
unclear if elongated HCECs are a desirable feature of a cell sheet transplant as HCECs in vivo 
are hexagonal and rounded. In another study by Teo et al., BCECs were seeded onto 
topographies of different geometries to screen for those that would elicit the most significant 
cellular responses [101]. The BCEC monolayer was then generated on micro- and nano-
scaled pillars and wells with results indicating higher microvilli density, lower coefficient of 




-ATPase immunofluorescence expression, 
mRNA up-regulation and function on nanopillars. However, as far as we know, there has not 
been any literature on the synergistic influence of topographical and biochemical cues on 
HCEC.  
1. 13. Hypothesis  
The hypothesis presented in this thesis is that in vitro extracellular environment in the form of 
topographical cues can differently regulate and improve human corneal endothelial cell 
morphometry and phenotype when different biochemical cues are used. 
1. 14. Aims  
The aims of the thesis are 
1. To study changes in HCEC-B4G12 behaviors by manipulating in vitro culture 
conditions in the form of different substrate topographies and ECM protein coatings. 
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2. To independently screen for the most optimal substrate topography that results in 
enhanced HCEC-B4G12 morphometry and phenotype when different ECM protein 
coatings are used; the finding will then be used as reference for tissue engineering 
corneal endothelium applications including cell culture platform for ocular drug 
testing and development. 
3. To do preliminary study of the selected combinations of substrate topography and 





Chapter 2 – Materials and Methods 
2. 1. Fabrication of Patterned Samples with Soft Lithography and Heat 
Embossing 
Surface patterns were fabricated onto polydimethylsiloxane (PDMS, Sylgard 184, Dow 
Corning) using soft lithography method. Elastomer mixture with 10:1 base to curing agent 
ratio was poured onto silanized nano-imprinted polycarbonate or silicon master mold, 
degassed in desiccator for 30 minutes, and baked at 60 ºC for 2 hours before PDMS substrate 
was gently peeled off from the master mold.  
Surface patterns were fabricated onto tissue culture polystyrene (TCPS, Corning) using heat 
embossing method. Patterned PDMS mold obtained from soft lithography was pressed onto 
TCPS at ~0.3-0.5 MPa for 90 seconds at 175 ºC followed by cooling at room temperature for 
another 90 seconds.  
The patterns were nanopillars, microwells, and micropillars with dimension of 250 nm 
diameter, 250 nm height, 500 nm pitch; 1 μm diameter, 1 µm depth, 6.7 µm pitch; and 1 μm 
diameter, 1 µm height, 6.7 µm pitch, respectively. Before being used as cell culture 
substrates, the samples were cleaned with absolute ethanol and plasma-treated for 45 seconds 
at 60 Watts and 80% O2 gas (FEMTO Science, Cute-B) to decrease surface hydrophobicity. 
Plasma treatment was excluded for 250 nm pillar samples as they had to be constantly kept in 
liquid. The samples were then sterilized with 70% ethanol and UV irradiation prior to coating 
with ECM proteins.  
2. 2. ECM Protein Coating on Samples 
After sterilization, PDMS and TCPS samples were coated for 2 hours at 37 ºC with either 10 
µg/ml of bovine fibronectin (Biological Industries) and 35 µg/ml of bovine collagen I 
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(Gibco) mixture or 2 ml/well for 6-well plate of FNC Coating Mix® (US Biological) or for 2 
hours at room temperature with filtered 10 µg/ml of laminin (natural mouse, Gibco) and 10 
mg/ml of chondroitin sulfate (sodium salt from shark cartilage, Sigma) mixture. The samples 
were then washed once with sterile filtered 1X phosphate buffered saline (PBS, 1st BASE) 
and immediately seeded with cells.   
2. 3. Fluorescence Staining of ECM 
PDMS samples were washed with filtered absolute ethanol and plasma-treated before coating 
with either one of the ECM protein coating mixtures. After 2-hour incubation, the samples 
were washed with 1X PBS and incubated with 1 μg/ml of Alexa Fluor® 546 Carboxylic Acid 
(Invitrogen) at 4 ºC overnight. The samples were then washed with 1X PBS and imaged 
using fluorescence microscope (Leica DM IRB). 
2. 4. Scanning Electron Microscopy (SEM) of Patterned PDMS and TCPS 
ECM-coated PDMS and TCPS samples were washed with 1X PBS and fixed for 1 hour with 
2% glutaraldehyde in 0.1 M sodium cacodylate and 0.003 M calcium chloride dissolved in 
filtered deionized (DI) water. They were then washed with sodium cacodylate buffer and 
dehydrated with series of ethanol gradient and transferred to hexamethyldisilazane (HMDS) 
through a graded series of ethanol-HMDS mixture and dried. For PDMS patterned with 250 
nm pillar, the samples were subjected to critical point drying (Tousimis Autosamdri-815) 
after serial dehydration with ethanol to minimize the surface tension between the pillars 
caused by capillary cohesive forces during solvent drying. Samples were sputter-coated with 
platinum (Jeol JFC-1600) and imaged with Jeol JSM-6010LV. Fixation step was excluded for 
uncoated PDMS samples, thus after washing, the samples were dried and directly sputter-
coated and imaged. 
2. 5. HCEC-B4G12 Culture 
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Clonal cell line HCEC-B4G12 (DSMZ, Braunschweig, Germany) [72] were cultured on 
tissue culture flask coated with filtered 10 µg/ml of laminin and 10 mg/ml of chondroitin 
sulfate constituted in 1X PBS. The medium consisted of Human Endothelial-SFM (Gibco) 
supplemented with 10 ng/ml of basic fibroblast growth factor (bFGF, Gibco). The cells were 
cultured in 5% CO2 incubator until they reached 90% confluence, after which they were 
passaged for experiments. The medium was changed every other day. The seeding density 
was kept at 6000 cells/cm
2
.  
2. 6. Primary HCEC Culture 
Primary HCECs were obtained from Dr. Jod Mehta’s group at Singapore Eye Research 
Institute at passage 2. The protocols conformed to the tenets of the Declaration of Helsinki 
and the study was approved by the institutional review board of the Singapore Eye Research 
Institute/Singapore National Eye Centre. Donor information is supplemented in Table 2.1 
below. 
Table 2.1. Donor information 
Serial 
Number 
Age Sex Days to 
Culture 
Cell Count (OS/OD) COD 
01(RT37) 22 F 7 3289/3289 Overdose 
02(RC198) 19 F 7 2882/2681 Acute Cardiac Crisis 
03 (RC270) 2 F 12 4348/4425 GI Bleed 
Table 2.1. Cultures of primary cells were established from donors aged 2-year-old to 22-year-old. Days taken from 
death of donor to the initiation of corneal endothelial cell culture ranged from 7 to 12 days. 
The cells were maintained in 5% CO2 incubator on tissue culture dish that had been coated 
with FNC Coating Mix®. Two different culture media were used, namely maintenance and 
proliferation medium. Maintenance medium consists of Human Endothelial-SFM 
supplemented with 5% fetal calf serum (Gibco) and 1% penicillin-streptomycin (Gibco). 
Proliferation medium consists of equal amount of Ham’s F12 and M99 supplemented with 
5% fetal bovine serum (Gibco), 20 µg/ml of ascorbic acid (Sigma), Gibco® Insulin, 
Transferrin, Selenium, Ethanolamine Solution (ITS-X) diluted to final concentration of 5 
 29 
 
µg/ml of insulin, 2.75 µg/ml of transferrin, 2.5 ng/ml of selenium, 1X antibiotic/ antimycotic 
(Gibco), and 10 ng/ml of bFGF. The medium was changed every other day. For experiments, 
the cells were detached by incubating them in TrypLE
TM
 Express (Gibco) for 15 minutes 
followed by gentle pipetting. After centrifugation to remove the enzyme, the cells were 
seeded onto PDMS or TCPS samples at seeding density of 15,000 cells/cm
2
, unless otherwise 
stated. The time point for experiments was 15 days, unless otherwise stated. 
2. 7. BrdU Proliferation Assay 
After 3 days in culture, HCEC-B4G12 cells were incubated for 4 hours with 0.5 µg/ml of 5-
bromo-2'-deoxyuridine (BrdU, Sigma), a synthetic analogue of thymidine that is incorporated 
into DNA when cell is dividing. The cell samples were then fixed with 4% paraformaldehyde 
(Sigma) dissolved in 1X PBS and permeabilized with 0.1% Triton X-100 in 1X PBS 
followed by treatment with 4 N HCl in DI water. After rinsing with filtered DI water, the 
samples were blocked with 10% goat serum (Gibco) and stained with mouse anti-BrdU 
antibody diluted 1:50 (Developmental Studies Hybridoma Bank, University of Iowa) in 1X 
PBS for 1 hour. Following primary antibody incubation, the samples were incubated with 
Alexa Fluor® 546-conjugated goat anti-mouse antibody diluted 1:1000 (Invitrogen) for 1 
hour and 4',6-diamidino-2-phenylindole (DAPI, Molecular Probes) diluted 1:2500 for 30 
minutes. All regions of the sample were imaged and analyzed using ImageJ (NIH Software). 
2. 8. EdU Proliferation Assay 
For EdU assay on primary HCEC, cells were seeded at density of 3,750 cells/cm
2
. After 3 
days in culture, the cells were incubated overnight with 10 µM of 5-ethynyl-2’–deoxyuridine 
(EdU) and subjected to subsequent steps according to protocol from Click-iT® EdU 
(Invitrogen). EdU is a nucleoside analog to thymidine and is incorporated into DNA during 
cell division. Different from BrdU assay in which DNA denaturation is required to expose the 
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BrdU for detection by antibody, EdU assay only requires standard aldehyde-based fixation 
and detergent permeabilization. EdU assay also allows antibody multiplexing against 
intracellular and surface markers. Detection of cell proliferation is based on copper-catalyzed 
covalent reaction between azide that is contained in the dye and alkyne contained in EdU 
[102].  




-ATPase, ZO-1, and F-actin 
For HCEC-B4G12, three days after forming confluent monolayer, the cell samples were fixed 
with 4% paraformaldehyde. For primary cells, cell samples were fixed at day 15. The 
samples were permeabilized with 50 mM glycine and 0.05% Triton X-100 constituted in 1X 




-ATPase surface marker staining. 
Samples were then blocked in 10% goat serum in 1X PBS. ZO-1 was labelled with mouse 









-ATPase α1 antibody (Santa Cruz) diluted 
1:40, both for 1 hour. The samples were subsequently incubated for 1 hour with Alexa 
Fluor® 546-conjugated goat anti-mouse antibody diluted 1:750, counterstained with 1:2500 
DAPI for 30 minutes, and mounted onto microscope slides for imaging. For F-actin staining, 
the samples were incubated with Alexa Fluor® 488 Phalloidin diluted 1:500 for 30 minutes 
before mounting.  
2. 10. Gene Expression Analysis 




-ATPase and ZO-1 was quantified with real-time polymerase 
chain reaction (qPCR) and qualitatively obtained with reverse-transcription polymerase chain 
reaction (RT-PCR). The cells were cultured as above and RNA was isolated with TRIzol®
 
Reagent (Life Technologies). For qPCR, TaqMan assay was run on Applied Biosystems 7500 
Fast Real-Time PCR Systems using TaqMan® Universal MMIX II with no UNG (Applied 
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Biosystems). TaqMan® Gene Expression Assay ID Hs00167556_m1 and Hs01551861_m1 




-ATPase and ZO-1, respectively. GAPDH with assay ID 
Hs02758991_g1 served as endogenous control. The expression levels across different 
samples were first normalized against their GAPDH control, after which they were 
normalized against the unpatterned control. For RT-PCR, primer pair sequence of ZO-1: 5'-





ATPase: 5'-GATGGGAAGAATTGCCACAC-3' and 5'-GGAAGATGACAGCCTCAAGC-
3', and human glyceraldehyde 3-phosphate dehydrogenase (GAPDH): 5’-
CTCATGACCACAGTCCATGC-3' and 5'-CTCTTGCTCAGTGTCCTTGC-3'. Target genes 
were amplified in 25 µl reaction volume for 35 cycles of 1 minute at 94 ºC, 1 minute at 59 ºC, 
1 minute at 72 ºC and final step of 10 minutes at 72 ºC. The products were run on 1.8% 
agarose gel and the bands were imaged. Densitometry analysis was performed with ImageJ 
software. 
2. 11. Protein Expression Analysis 
HCEC-B4G12 cells were cultured as above and the protein was extracted three days after 
confluent monolayer formation with RIPA buffer (Pierce) containing protease inhibitor 
cocktail (Sigma) diluted 1:100, 1 µg/ml of phenylmethylsulfonyl fluoride (PMSF, Sigma) 
dissolved in methanol, and 1 µg/ml of sodium orthovanadate (Sigma) dissolved in DI water. 
The samples were centrifuged and the supernatant containing the protein was extracted. The 
protein was then concentrated with centrifugal filter units (10K, Amicon) and quantified with 
Micro BCA Protein Assay (Pierce). The protein samples were run on precast polyacrylamide 
gel (4-15%, Bio-Rad) and transferred to PVDF membrane (Bio-Rad) before blocking in 





ATPase α1 (Merck Millipore) diluted 1:1000 or mouse ZO-1 monoclonal antibody (Novex) 
diluted 1:250 overnight. They were then incubated with goat anti-mouse HRP (Santa Cruz) 
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for 1 hour. The proteins of interest were detected with ECL Reagents (GE Healthcare) on X-
ray film (Fujifilm). Densitometry analysis was performed using ImageJ on the bands by 
normalizing each sample against GAPDH control followed by normalization against 
unpatterned control.  
2. 12. Morphometric Measurement  
As ZO-1 expression is localized at the cell border and thus outlines the cell shape, ZO-1- 
immunostaining images were used to calculate individual cell circularity and area. The 
images were opened in ImageJ software, scale bar was set according to microscope 
magnification of the images, and individual cell was manually outlined using ‘Freehand 
selections’ tool. By clicking ‘Measure’ function under ‘Analyze’, the software automatically 
calculated circularity and area value of that individual cell. Using approximately 50 cells 
within a sample in each independent experiment, coefficient of variation (CV) of cell area 
was obtained by dividing standard deviation of cell area with the average cell area of that 
sample.  
2. 13. Statistical Analysis 
Data are presented as mean ± SD of n runs of the same experiment with n indicated in the 
figure legend of each figure. In general, for HCEC-B4G12, three runs for each experiment 
(n=3) were conducted. For primary HCEC, due to limited amount of primary cells available, 
one run for each experiment (n=1) was performed. In each run, there were 1 or 2 replicates 
for morphometry analysis, 3 replicates for qPCR experiments, and 1 sample for Western Blot. 
Student's t-test and ANOVA were used to evaluate the statistical significance where 




Chapter 3 – Results 
3. 1. Scanning Electron Microscopy and Immunofluorescence Staining of ECM 
Protein Coating on PDMS  
 
 
Figure 3. 1. (A) SEM images of unpatterned and patterned PDMS samples coated with either one of the ECM protein 
coatings. Scale bar = 2 µm. (B) SEM image of 250 nm pillar master template showing clogging in some areas. 
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Scanning electron microscopy images indicate that the micro-scaled patterns were replicated 
with fidelity on the PDMS surface and the ECM protein coatings did not obscure the patterns 
(Figure 3.1 A). While ECM protein coatings did not mask 250 nm pillar, there was absence 
of distinct pattern structure in some parts of the replicated PDMS samples. Subsequently, 
SEM image of the master template indicates that it had been partially clogged (Figure 3. 2 B, 
contributed by R. Muhammad). The clogged areas were signified by regions with darker 
irregular appearance, some of which were highlighted in red circles. 
As shallow features such as 250 nm pillars had also been found to be prone to deformation 
and collapse [103-105], we reduced the tendency of adjacent nanopillars to merge with each 
other due to contact-associated deformation under pressure and deformation caused by force 
when demolding by completely immersing the features in liquid at all time during demolding, 
storing, and experiment. 
 
Figure 3. 2. Fluorescence staining of ECM protein coatings on PDMS. Scale bar = 100 µm, inset = 20 µm. 
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As all the images were taken using the same exposure, fluorescence staining of ECM protein 
coatings on PDMS indicates the presence of ECM protein as shown by the high background 
on the coated surface and the lack thereof on the uncoated surface. Inset images indicate 
formation of fine fibrillar network on FC-PDMS and occasional aggregation of matrix 
proteins on FNC- and LC-PDMS (Figure 3.2).    
3. 2. HCEC-B4G12 
3. 2. 1. Attachment and Proliferation  
 
Figure 3. 3. HCEC-B4G12 attachment on uncoated PDMS, PDMS coated with either one of the ECM protein 
coatings, and uncoated TCPS 4 hours after seeding. In all incubation conditions, the cells had consistently higher 
attachment on FC- and FNC-PDMS than on LC-PDMS (n = 1). 
HCEC-B4G12 were seeded onto uncoated PDMS, PDMS coated with different ECM protein 
coatings, and uncoated TCPS for 4 hours. The single point at room temperature was 
originally the protocol for LC coating on tissue culture flask (personal communication with 
G. Peh). However, we usually incubated coated PDMS at 37 ºC [101, 106-107]. 
Consequently, the author tested initial cell attachment on LC coating at different time points 
at 37 ºC in addition to the given time point at room temperature. 
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The unattached cells were washed away with PBS, leaving the adherent cells which were 
trypsinized and counted with hemocytometer. With different conditions of coating time and 
temperature, the amount of cells attached was consistently higher on PDMS coated with FC 
and FNC than on PDMS coated with LC (Figure 3.3). Cell attachment on LC-PDMS with 
coating condition of 24 hour at 37 ºC was comparable to that of uncoated PDMS, with 25% 
and 26.6% of total cells attached, respectively. The highest cell attachment on FC- and FNC-
PDMS was achieved with coating time and temperature of 2 hours and 37 ºC, respectively, 
with more than 60% of total cells already adherent to the PDMS substrates. On the other 
hand, the highest cell attachment on LC-PDMS was with coating time of 2 hours at room 
temperature with 30.6% of total cells adhered. Coating conditions that resulted in the highest 







Figure 3. 4. (A) HCEC-B4G12 cells were incubated with 0.5 µg/ml of BrdU for 4 hours after 3 days in culture. The 
amount of nuclei incorporating BrdU was calculated against the total number of DAPI-stained nuclei. The cells on 
FC- and FNC-PDMS had an overall higher proliferation rate than those on LC-PDMS (n = 3). (B) Representative 
images of BrdU incorporation by HCEC-B4G12 after 3 days in culture. Scale bar = 20 µm. 
BrdU cell proliferation assay signifies that HCEC-B4G12 had an overall higher proliferation 
rate on FC- and FNC-PDMS than on LC-PDMS at day 3 in culture (Figure 3.4 A). On FC-
PDMS, the cells on 1 µm pillar had the lowest proliferation rate although it was not 
statistically significant. On the other hand, the same pattern on FNC-PDMS induced the 
highest proliferation rate. On LC-PDMS, HCEC-B4G12 on 250 nm pillar had significantly 
lower proliferation rate (16.6±2.36 %) as compared to other patterns (16.4±4.07 % for 1 µm 
well and 25.2±0.14 for 1 µm pillar, both p < 0.005) and unpatterned control (27.2±3.91, p < 
0.005).  
Due to the difference in overall proliferation rate on different ECM protein coatings, HCEC-
B4G12 reached confluence at different time points. While it took 7 days for the cells to be 
confluent on FC- and FNC-PDMS, it took 14 days for the cells on LC-PDMS to reach the 
same state.  
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-ATPase and (B) ZO-1 expressed by HCEC-B4G12 after 3 
days of confluent monolayer formation indicates expression of both functional biomarkers by cells on all patterns 
coated with different ECM protein coatings. Scale bar = 20 µm. 
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-ATPase was localized mostly on cell-to-cell 
borders while ZO-1 formed interdigitation on the cell boundaries, connecting neighbouring 
cells. Nevertheless, from the images, no significant difference in expression level could be 
observed among the different pattern and protein coating combinations. Nuclei staining 
indicated that HCEC-B4G12 on FC- and LC-PDMS formed a uniform and confluent 
monolayer with well-distributed cells while those on FNC-PDMS formed confluent patches 
interspersed with open areas.  




-ATPase and ZO-1 Gene Expression  
 




-ATPase and ZO-1 gene expression of HCEC-B4G12 was analyzed 3 days after the cells formed 
confluent monolayer. The expression level was determined qualitatively with RT-PCR. The expression was 
normalized against GAPDH and the respective unpatterned control (n = 1).  




-ATPase and ZO-1 gene 
expression using ImageJ software indicates that on FC-PDMS, expression of both functional 
biomarkers on 1 µm pillar was higher than on other patterns but lower than the unpatterned 
 40 
 





ATPase expression and those on 250 nm pillar had the highest ZO-1 expression. On LC-
PDMS, cells on 250 nm pillar had the highest expression of both biomarkers in comparison to 










-ATPase  and (B) ZO-1 gene expression of HCEC-B4G12 after 3 days of confluent monolayer 
formation. The expression level was determined semi-quantitatively by real-time qPCR. The expression was first 
normalized to GAPDH and then to the respective unpatterned control. Multifold increase in expression as compared 




-ATPase (n = 3). 
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-ATPase and ZO-1 gene expression indicates that 
on FC-PDMS, HCEC-B4G12 on 1 µm pillar had the highest expression of both functional 
biomarkers in comparison to other patterns and the unpatterned control although the 
difference is only statistically significant for ZO-1 between 1 µm pillar and 250 nm pillar (p 
< 0.005, Figure 3.7). On FNC-PDMS, cells on 250 nm pillar had the highest ZO-1 expression 
among other patterns and the unpatterned control, with 6.5 folds higher expression than the 




-ATPase expression of 
0.3 folds of the unpatterned control (p < 0.005). On LC-PDMS, cells on 250 nm pillar had the 




-ATPase expression, with expression level of 
8.1 folds (p < 0.05) and 0.2 folds (p < 0.005) as compared to the unpatterned control, 
respectively. On both 1 µm well FC- and LC-PDMS, HCEC-B4G12 expressed more ZO-1 (p 




-ATPase (p < 0.05 for FC and p < 0.005 for LC) than their 
respective unpatterned control. 

















-ATPase and (B) ZO-1 protein expression of HCEC-B4G12 after 3 days of confluent 
monolayer formation. The expression level was obtained from Western Blot and normalized against GAPDH and the 
respective unpatterned control. On FC-PDMS, HCEC-B4G12 on 1 µm pillar had higher expression of both markers 
than other patterns and the unpatterned control. On LC-PDMS, cells had higher expression of both markers on 250 




-ATPase was lower than the unpatterned 
control (n=3). 
Western Blot densitometry graph obtained by measuring blot density using ImageJ software 




-ATPase and ZO-1 protein 
expression on 1 µm pillar, with 1.40 folds and 1.37 folds higher expression than the 
unpatterned control, respectively (Figure 3.8). However, the difference is not statistically 
significant (p = 0.478 and p = 0.438, respectively). Within the same coating, the cells had 





-ATPase and ZO-1 expression, respectively, than the unpatterned control. On 
FNC-PDMS, cells on 250 nm pillar expressed the highest level of ZO-1 (1.6 folds as 




-ATPase expression on all 
patterns was considerably lower than the unpatterned control (p < 0.05 for 250 nm pillar and 
1 µm well, p = 0.124 for 1 µm pillar). On LC-PDMS, cells on 250 nm pillar had higher 
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ATPase was lower than the unpatterned control. 
3. 2. 5. Morphometric Parameters  
 
Figure 3. 9. HCEC-B4G12 cell circularity after 3 days of confluent monolayer formation on PDMS. The circularity 
was measured using ImageJ software by manually outlining individual cell boundaries from ZO-1 staining images. 
Circularity was at least 0.77 for all patterns coated with either one of the three ECM protein coatings (n = 3). 
Cell circularity of HCEC-B4G12 seeded on all patterns coated with either one of the three 
ECM protein coatings, as measured by outlining cell boundaries from ZO-1 staining images 
using ImageJ software, was above 0.77 (Figure 3.9). On FC-PDMS, cells on 1 µm pillar had 
circularity value of 0.874±0.006, which was significantly higher than that of other patterns 
(0.766±0.048 on 250 nm pillar and 0.811±0.021 on 1 µm well, both p < 0.005) and the 
unpatterned control (0.809±0.028, p < 0.005). On FNC-PDMS, cells had the highest 
circularity on 1 µm well (p < 0.005 for unpatterned control and 250 nm pillar, p = 0.583 for 1 
µm pillar). On LC-PDMS, 1 µm well induced significantly higher circularity (0.836±0.013) 
than other patterns (0.823±0.016 on 250 nm pillar and 0.812±0.041 on 1 µm pillar; p < 0.05 




Figure 3. 10. HCEC-B4G12 cell area after 3 days of forming confluent monolayer. The area was measured using 
ImageJ software by manually drawing outline of individual cell boundaries from ZO-1 staining images. Cells had an 
overall smaller area when cultured on FNC-PDMS than on FC- and LC-PDMS (n = 3). 
HCEC-B4G12 cell area was in overall largest on FC-PDMS and smallest on FNC-PDMS 
(Figure 3.10). Cell area on FNC-PDMS and most of LC-PDMS was within the normal in vivo 
range of approximately 250 µm
2
 to 550 µm
2 
[108-110]. On FC-PDMS, HCEC-B4G12 had 
significantly smaller cell area on 1 µm pillar (762±8.54 µm
2
) than on other patterns 
(1172±241 µm
2 
on 250 nm pillar and 1012±110 µm
2
 on 1 µm well, p < 0.005) and the 
unpatterned control (989±130 µm
2
, p < 0.005). Comparing among samples within the same 
coating, on FNC- and LC-PDMS, cell area was also smallest on 1 µm pillar (p < 0.005, 




Figure 3. 11. CV of HCEC-B4G12 cell area after forming confluent monolayer for 3 days on PDMS. CV of cell area 
was calculated by dividing standard deviation of individual cell area with the mean cell area (n = 3). 
Figure 3.11 indicates that on FC- and LC-PDMS, HCEC-B4G12 had CV of cell area values 
that were within physiological range of 20-30% [111-112]. On the other hand, cells on FNC-
PDMS had CV of cell area that was higher than the normal range. The most uniform cell 
area, as signified by the lowest CV, compared within each of the protein coatings was 
unpatterned FC (21.9±3.30%), 1 µm pillar FNC (34.6±11.6%), and 250 nm pillar LC 
(22.3±4.14%).  
3. 3. Primary HCEC 
As experimental findings with HCEC-B4G12 indicate failure of FNC-PDMS to induce 
confluent monolayer, the coating was excluded in experiments with primary HCEC on 
PDMS. In addition, as 1 µm pillar and 250 nm pillar induced HCEC-B4G12 to have 
cumulatively better cellular morphometry and phenotype on FC- and LC-PDMS, 




3. 3. 1. Optimization of Analysis Time Point  
Since the response of primary HCEC to PDMS culture substrate and topography was 
unknown, optimization experiment was conducted to determine the best time point to study 
cellular morphological and functional expression. 
 
Figure 3. 12. Phase-contrast microscope image of primary HCECs on FNC-coated culture dish before passaging for 
experiments indicates typical HCEC morphology.  
Primary HCECs on FNC-coated culture dish in maintenance medium were confluent and 









Figure 3. 13. Phase-contrast microscope images of primary HCECs at day (A) 7, (B) 15, and (C) 29 in culture in 
maintenance medium on PDMS suggest adoption of different morphology on different combinations of pattern and 
ECM protein coating and at different time points. Scale bar = 100 µm. 
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Primary HCECs were seeded at seeding density of 15,000 cells/cm
2
. Observation of primary 
HCECs under phase-contrast microscope after 7 days in culture on PDMS substrate in 
maintenance medium indicates that the cells exhibited different morphology on different 
patterns coated with different ECM proteins (Figure 3.13 A). On FC-PDMS, primary HCECs 
were mainly elongated on unpatterned control and 250 nm pillar but were moderately 
rounded and spread on 1 µm pillar. On LC-PDMS, the cells had a rounded shape on the 
unpatterned control and 1 µm pillar but were relatively spread on 250 nm pillar. In overall, 
the number of cells and the extent of cell spreading appear to be larger on FC-PDMS than on 
LC-PDMS. 
After 15 days in culture in maintenance medium, most cells on all combinations of pattern 
and protein coating exhibited typical cultured HCEC morphology of spread circular shape 
(Figure 3.13 B). Cell count at this time point was higher than at day 7 with cells on most 
samples appeared to be confluent or near confluent.  
Prolonged culture until 29 days did not lead to improvement of cellular morphology (Figure 
3.13 C). Instead of forming mature confluent monolayer with uniform cell area and shape, 
long culture resulted in primary HCECs on most samples undergoing morphological changes 
and decrease in cell count. Cell count was reduced on all samples except on unpatterned FC-
PDMS and 1 µm pillar LC-PDMS. On FC-PDMS, primary HCECs most closely resembled 
typical HCEC morphology on the unpatterned control. Cells on 1 µm pillar, on the other 
hand, had abnormal cell shape with elongated and branched cell body, strongly indicating 
that they had undergone dedifferentiation into other cell type. Cells on 250 nm pillar showed 
unhealthy spherical clumped morphology. On LC-PDMS, primary HCECs retained normal 
HCEC morphology. However, they were sparsely distributed, with the exception of 250 nm 
pillar on which the cells appear to retain their confluent state.  
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The above observation led to the conclusion that the most optimal analysis time point for all 
combinations of pattern and ECM protein coating is day 15. As such, subsequent experiments 
were conducted at this time point.  




-ATPase, ZO-1, and F-actin Immunofluorescence Staining 
 




-ATPase expressed by primary HCECs after 15 days in culture 
in maintenance medium on PDMS indicates variable levels of expression of the biomarker on different combinations 
of pattern and protein coating. Scale bar = 100 µm. 





-ATPase when subjected to different patterns coated with different ECM protein 





-ATPase. On 250 nm pillar, on the other hand, most cells expressed the 




-ATPase was not detected on cells cultured on 




Figure 3. 15. Immunofluorescence staining of ZO-1 expressed by primary HCECs at day 15 in culture in maintenance 
medium on PDMS. Results indicate variable expression of the biomarker. Scale bar = 100 µm. 
ZO-1 level expressed by primary HCECs was variable on different patterns coated with 
different ECM protein coatings (Figure 3.15). On FC-PDMS, ZO-1 was only detected in 
some of the cells on 1 µm pillar while it was expressed by most cells on unpatterned control 
and 250 nm pillar. The marker, however, appears to be mainly localized within the cytoplasm 
instead of at the cell-to-cell borders. On LC-PDMS, ZO-1 was expressed by only some of the 
cells on unpatterned control and 1 µm pillar. The cells on 250 nm pillar, on the other hand, 
had higher level of expression of the functional marker with most of the staining detected at 




Figure 3. 16. Fluorescence staining of F-actin expressed by primary HCECs at day 15 in culture in maintenance 
medium on PDMS. Images indicate that cells were near confluent on unpatterned control but were relatively sparse 
on patterns. Scale bar = 100 µm. 
F-actin fluorescence staining of primary HCECs after 15 days in culture in maintenance 
medium indicates that on both FC- and LC-PDMS, cells were near confluent on unpatterned 
control but were relatively sparse on patterns (Figure 3.16). Similar to observation with 
phase-contrast microscope, the cells mainly exhibited spread circular shape typical of HCEC 
morphology. 




Figure 3. 17. Primary HCEC cell circularity after 15 days in culture in maintenance medium on PDMS. The value 
was calculated using ImageJ by manually outlining individual cell boundaries from ZO-1 staining images and 
confirmed with remeasurement using F-actin staining images. Results signify that circularity value is not significantly 
different among patterns and unpatterned control within the same coating (n = 1). Standard deviation indicates 
variation of cell circularity value within the same sample. 
At day 15 in culture on PDMS in maintenance medium, cell circularity of primary HCECs 
within the same coating was similar among patterns and unpatterned control (Figure 3.17). 
Cells cultured on LC-PDMS had circularity value ranging from 0.80 to 0.82 and cells on FC-
PDMS had circularity value from 0.73 to 0.75  
 
Figure 3. 18. Primary HCEC cell area on PDMS after 15 days in culture in maintenance medium. The area was 
measured using ImageJ software by manually drawing outline of individual cell boundaries from ZO-1 staining 
images and confirmed with remeasurement with F-actin staining images. Cells on patterns had lower cell area than 
those on unpatterned control (n = 1). Standard deviation indicates variation of cell area within the same sample. 
Figure 3.18 indicates that cell area of cultured primary HCECs on both FC- and LC-PDMS 
was larger than the normal in vivo range of 250-550 µm
2
 [108-109]. On both coatings, cell 
area was lower on patterns than the unpatterned control with 1 µm pillar inducing the lowest 
cell area (3100±1614 µm
2
 and 3037±1707 µm
2
, respectively) as compared to 250 nm pillar 
(4214±2273 µm
2
 and 3544±1598 µm
2
, p < 0.005 and p = 0.137, respectively) and the 
unpatterned control (4408±1649 µm
2
 and 4862±2749 µm
2
, p < 0.005). Although on both 
coatings cell area on 250 nm pillar was lower than the unpatterned control, the difference was 




Figure 3. 19. CV of cell area of primary HCECs after 15 days in culture in maintenance medium on PDMS. The value 
was calculated by dividing standard deviation of individual cell area with the average cell area. Results indicate that 
on LC-PDMS, 250 nm pillar had the lowest cell area (n = 1). 
As shown in Figure 3.19, primary HCECs after 15 days in culture had CV of cell area that 
was higher than the in vivo healthy range of 20-30% [111-112]. On FC-PDMS, cells had the 
lowest CV of cell area on unpatterned control (37.4% as compared to 53.9% on 250 nm pillar 
and 52.1% on 1 µm pillar). On LC-PDMS, the lowest CV of cell area was exhibited by cells 
on 250 nm pillar (45.1% as compared to 56.5% on unpatterned control and 56.2% on 1 µm 
pillar). 
3. 3. 4. Preliminary Results on TCPS Culture 
The inability of primary HCECs on PDMS to reach confluence at any time point necessitates 
optimization of culture conditions. While a few parameters such as medium composition and 
protein coating incubation period can be optimized, we kept them constant and instead 
substituted PDMS with TCPS. Our preliminary results provide a hint at the influence of 






3. 3. 4. 1. SEM of ECM Protein Coating on TCPS 
 
Figure 3. 20. SEM images of patterned TCPS samples coated with either one of the ECM protein coatings indicate 
that FC partially masked 250 nm pillar while FNC and LC did not mask any pattern.  
Scanning electron microscope images of patterned TCPS samples coated with FC, FNC, or 
LC protein coating indicate that both micro- and nano-topographies were replicated with 
fidelity and that FC formed dense fibrillar network that partially masked 250 nm pillar pattern 
(Figure 3.20). FNC and LC coatings, on the other hand, did not mask any of the patterns.  
As a consequence of the masking, FC was excluded from subsequent experiments on TCPS 
substrate. In addition, as the mechanical and chemical properties of PDMS and TCPS are 
different, findings obtained from HCEC-B4G12 on PDMS cannot be used as reference to 
screen for pattern and protein coating that may lead to improved cell behavior of primary 
cells on TCPS. As a consequence, both FNC coating and 1 µm well pattern, which were 
excluded in experiments on PDMS substrate, were included in experiments on TCPS.  
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Figure 3. 21. Immunofluorescence staining of (A and B) ZO-1 and fluorescence staining of (C) F-actin expressed by 
primary HCECs at day 15 in culture in maintenance medium on TCPS. Images indicate that cells formed confluent 
monolayer on all combinations of pattern and ECM protein coating. Scale bar = 100 µm. 
ZO-1 staining indicates that primary HCECs on TCPS on all patterns coated with different 
protein coatings expressed the biomarker at cell-to-cell borders although the staining was 
weak (Figure 3.21 A). Figure 3.21 B are enlarged images of the respective squares in Figure 
3.21 A showing the presence of ZO-1. F-actin fluorescence staining indicates that primary 
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HCECs were able to form confluent monolayer. The cells on 1 µm pillar FNC-TCPS 
appeared to be more elongated and irregularly shaped than those on other combinations of 
pattern and protein coating. Primary HCECs on 250 nm pillar and 1 µm pillar LC-TCPS 
appeared more polygonal and circular as compared to cells on other combinations of pattern 
and protein coating. 





Figure 3. 22. Primary HCECs were incubated with 10 µM EdU overnight after 3 days in culture in either (A) 
maintenance or (B) proliferation medium. The amount of nuclei incorporating EdU was calculated against the total 
number of DAPI-stained nuclei. In maintenance medium, the cells on the unpatterned control had lower proliferation 
rate than those on patterns. In proliferation medium, on LC-TCPS, cells on 250 nm pillar had the lowest proliferation 
rate (n = 3).  
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The amount of EdU incorporation after 3 days in culture on TCPS was higher in proliferation 
medium than in maintenance medium (Figure 3.22). In maintenance medium, on both FNC- 
and LC-TCPS, primary HCECs had the lowest proliferation rate on the unpatterned control 
(3.66±1.83 % and 2.16±1.07 %, respectively). Nevertheless, this low proliferation rate was 
only statistically significant on LC-TCPS (p < 0.05 for 1 µm well and 1 µm pillar). On FNC-
TCPS, the cells had the highest proliferation rate on 1 µm well although it was only 
statistically significant between 250 nm pillar and 1 µm well (p < 0.05). On LC-TCPS, cells 
on 1 µm pillar had the highest proliferation rate (p < 0.05 between the unpatterned control 
and 1 µm pillar). In proliferation medium, on both FNC- and LC-TCPS, primary HCECs had 
the lowest proliferation rate on 250 nm pillar (18.8±8.28 % and 8.11±5.47 %, respectively) 
although it was not statistically significant except between the unpatterned control and 250 
nm pillar on LC-TCPS (p < 0.05). On FNC- and LC-TCPS, the highest proliferation rate was 
on 1 µm well and unpatterned control, respectively. 
3. 3. 4. 4. Morphometric Parameters 
 
Figure 3. 23. Primary HCEC cell circularity after 15 days in culture in maintenance medium on TCPS. The value was 
calculated using ImageJ by manually outlining individual cell boundaries from ZO-1 staining images and confirmed 
with remeasurement using F-actin staining images. Results indicate that circularity values were similar across all 




Cell circularity of primary HCECs on FNC-TCPS in maintenance medium ranged from 0.702 
to 0.737 while that on LC-TCPS ranged from 0.753 to 0.801 (Figure 3.23). The difference 
among the patterns within the same ECM protein coating was not significant.  
 
Figure 3. 24. Primary HCEC cell area after 15 days in culture in maintenance medium on TCPS. The area was 
measured using ImageJ software by manually drawing outline of individual cell boundaries from ZO-1 staining 
images and confirmed with remeasurement using F-actin staining images. On FNC-TCPS, cells on patterns had lower 
cell area than those on the unpatterned control (n = 1). Standard deviation indicates variation of cell area within the 
same sample. 
Figure 3.24 shows that on FNC-TCPS, cell area of primary HCECs was lower on patterns 
than on the unpatterned control (8294±4125 µm
2
 on 1 µm well, p < 0.05, and 10181±3793 
µm
2
 on 1 µm pillar, p = 0.577, as compared to 11448±6716 µm
2
 on the unpatterned control). 
On LC-TCPS, 1 µm pillar induced the lowest cell area with cell area of 6383±3664 µm
2 
as 
compared to 10040±4091 µm
2
 on the unpatterned control (p < 0.05) and 11462± 4947 µm
2
 




Figure 3. 25.  CV of cell area of primary HCECs after 15 days in culture in maintenance medium on TCPS. CV of cell 
area was calculated by dividing standard deviation of individual cell area with the average cell area. (n = 1). 
As shown in Figure 3.25, on FNC-TCPS, CV of cell area of primary HCECs was lower on 
patterns than on the unpatterned control (49.7% on 1 µm well and 37.3% on 1 µm pillar as 
compared to 58.7% on the unpatterned control) with 1 µm pillar inducing the lowest CV of 
cell area. On LC-TCPS, the lowest CV of cell area was by cells on the unpatterned control 




Chapter 4 – Discussion 
4. 1. HCEC-B4G12 
In this research thesis, we demonstrated that surface nano- and micro-topographical cue 
coated with ECM protein coating as biochemical cue, differently regulated proliferation, 
morphometry, and phenotype of HCEC-B4G12. In addition, specific combinations of these 
two cues improved cellular behavior. We validated changes in Na+/K+-ATPase and ZO-1 
expression with different methods, namely immunofluorescence staining, real time qPCR, 
RT-PCR, and Western Blotting.  
The human corneal endothelial cells lie on the Descemet’s membrane, the basement 
membrane secreted and deposited by the corneal endothelium and comprised of a number of 
proteins including fibronectin, laminin, collagen IV and VIII, as well as proteoglycans. Cells 
in vivo, including corneal endothelial cells, are subjected to unique and complex extracellular 
matrix environment. The topographical, biochemical, and mechanical properties of the 
extracellular matrix environment are tissue-specific and distinctly heterogeneous. Besides 
serving as structural support and strength as well as attachment sites for cell surface 
receptors, they can initiate specific cell signalling pathways to regulate cellular behaviors and 
are crucial in directing essential morphological organization and function by exerting changes 
in cell-cell and cell-matrix interactions as well as gene expression [92, 113-117]. This signal 
transduction is mediated by cell surface receptors for ECM proteins such as integrins [23, 
118]. Our aim is to investigate if a culture system, which mimics extracellular 
microenvironment, is able to induce favorable human corneal endothelial cell proliferation 
with good morphometry and phenotype for use in tissue engineering cornea endothelium.  
In order to construct tissue-engineered cornea endothelium, there have been studies in which 
denuded human amniotic membrane, collagen I matrices, and silk fibroin coated with 
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collagen IV, FNC, and a chondroitin sulphate-laminin mixture, were tested as potential 
substratum for corneal endothelial cell growth and carrier [65, 69, 100]. In our attempt to 
recapitulate the native environment, apart from introducing several mixtures of ECM protein 
coating, we incorporated substrate nano- and micro-topography. We selected a few 
combinations of commonly used ECM protein coatings and independently observed which 
topography would prevail on each ECM coating. This different extracellular milieu may 
induce specific integrin expression that guides the cells toward specific phenotype 
expression.  
For the choice of ECM protein coating, we used fibronectin-collagen I (FC), FNC Coating 
Mix® (FNC), and laminin-chondroitin sulfate (LC). We used laminin-chondroitin sulfate 
mixture as it was originally used as coating in the cultivation and expansion of HCEC-B4G12 
[74]. Although chondroitin sulfate, unlike laminin, is not a known constituent of Descemet’s 
membrane, it is one of the major glycosaminoglycans constituting the corneal stroma and has 
been shown to enhance primary human corneal endothelial cell growth when used above 
certain concentration [1, 119-120]. Besides, it has a protective effect on corneal endothelium 
in organ culture [121]. Similarly, collagen I is not found in Descemet’s membrane and 
instead found predominantly in the corneal stroma [122]. We used fibronectin-collagen I 
mixture with the same concentration as that of FNC, an ECM coating commonly used in 
corneal endothelial cell culture [78, 83, 123]. FNC itself is a commercially available cell 
attachment media containing bovine fibronectin, bovine collagen I, bovine albumin, among 
other inert components such as sodium and potassium chloride, sodium phosphate, and 
glucose [124]. The complete components and the exact composition of other components 
besides fibronectin and collagen I are proprietary to the company (AthenaES) and hence 
unknown. The topography that we tested was of isotropic pillars and wells as they were more 
likely to induce the cells to exhibit circularity and cell area uniformity compared to channels 
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and gratings as evidenced in the better cellular behavior in our screening study using bovine 
corneal endothelial cells [101]. Nevertheless, as the focus of the thesis was more on 
topography than ECM, the different ECMs functioned “merely” to screen for the optimal 
ones that could induce at least a confluent HCEC monolayer, besides enhancing cell 
attachment. This thesis had done so by showing that FNC coating on PDMS was not suitable 
for HCEC culture, even though FNC had been widely used as surface coating in many other 
studies [123-126] and worked well on TCPS with primary HCEC as shown in our 
preliminary study. The fact that only certain commonly used ECM protein coatings were 
suitable for culture of particular cells on particular substrates warranted the importance of 
careful selection of coatings in the first place. Once the basic purposes of coating, which in 
this thesis are to enhance cell attachment and induce cells to form uniform and confluent 
monolayer, was fulfilled, then the investigation of the effects of topography would have any 
significance. As such, even though for each data set, the results of topographies on the three 
ECMs were combined, data description and interpretation were done independently for each 
ECM. In other words, the purpose of the study was to separately investigate which 
topography would prevail on each of the ECM protein coatings tested. 
Our SEM images indicated that the micro-topographies were generated on PDMS with high 
fidelity. However, we observed a partial absence of distinct 250 nm pillars in some parts of 
the samples. Previous studies have reported that PDMS (Sylgard 184 used in our study) had 
low Young’s modulus and hence low structural strength which may cause shallow features to 
be prone to deformation and collapse [103-105, 127]. Pattern density is also an increasingly 
significant problem when the features are nano-scaled as critical Young’s modulus of pattern 
is inversely proportional to quadratic power of gap distance and cubic power of pattern 
diameter [128]. In addition, base to curing agent ratio, temperature and period of 
crosslinking, handling of the samples, as well as size, aspect ratio and density of topographic 
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features may contribute to pillar collapse [129]. Hence, to minimize the chance of collapse, 
we used the standard base to curing agent ratio of 10:1 which is in the optimal range [129]. 
We also reduced the tendency of adjacent nanopillars to merge with each other due to 
contact-associated deformation under pressure and deformation caused by force when 
demolding by completely immersing the features in liquid at all time during demolding, 
storing, and experiment. Demolding the nanopillars in the liquid also shortens the time taken 
for the liquid to exert capillary force and adhesion on the pillars. When the recessed features 
of PDMS are completely filled with liquid, surface tension is no longer exerted by the liquid 
[128]. Storing by immersing in liquid and hence complete filling of the recesses among the 
pillars also prevents the pillars from contacting with each other and undergoing deformation 
and collapse.  
Initially, we inferred that the absence of distinct pillars in some parts of the samples was 
caused by pillar collapse due to accidental exposure of the samples to the air during 
preparation for and the processes of critical point drying for SEM analysis. Air exposure 
increases the surface tension between the pillars due to capillary cohesive forces when the 
solvent evaporates from the surface, pulling on the pillars and inducing partial lateral 
collapse. However, upon subsequent investigations conducted recently by a graduate student 
in the lab, we found that the cause may instead be ascribed to clogging of the wells of the 
master template in some areas which consequently led to replication of shallow or no pillars 
in the affected areas. Clogging of master template due to deposition of residual uncrosslinked 
PDMS from repeated casting had also been shown in other studies [130-131]. Nevertheless, 
SEM imaging of 250 nm pillar coated with ECM protein coatings was only conducted after a 
considerable amount of time had passed since the cell analysis was completed and many 
additional replications had taken place. While the robustness of master templates depends on 
several factors including the material they are made of, fabrication methods they are utilized 
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in, and handling by users, it is not yet determined how many cycles could take place before 
they start to deteriorate even with good handling. Nevertheless, for soft lithography, the 
reported range was from at least 7 to over 100 for PDMS [131-134] and at least 30 for silicon 
wafer [131]. Thus, our 250 nm pillar silicon master template reusability may have ended 
when the samples were replicated for SEM analysis. From this incident, we learnt that we 
needed to implement a more regular checking of patterns especially during the period of cell 
analysis. 
Difference in initial cell attachment rate was observed when HCEC-B4G12 was seeded onto 
different ECM protein coatings with cells attaching more slowly on LC-PDMS than on FC- 
and FNC-PDMS. For each of the coating, we then selected incubation condition that resulted 
in the highest attachment. The higher cell attachment than uncoated PDMS after PDMS 
incubation with the selected condition for each ECM protein coating also indirectly supported 
our result of ECM fluorescence staining which showed that the coatings were presented to the 
cells during cell seeding and subsequently helped with cell attachment. The cells also had 
lower attachment affinity to PDMS than to TCPS, which was in agreement with previous 
studies by other groups [135-136]. However, we chose PDMS as our culture substrate as its 
Young’s Modulus of 0.6-2 MPa [137-140] more closely resembles that of normal cornea and 
Descemet’s membrane, which has Young’s Modulus of approximately 0.29 MPa and 2.57 
MPa, respectively [141-142]. The Young’s Modulus of TCPS, on the other hand, is on the 
order of GPa [143].  




is present between the aqueous humor and the 
corneal stroma with the aqueous humor having higher gradient of Na
+ 
and stroma having 
higher gradient of K
+
. As a consequence, there is a constant flux of Na
+
 from the aqueous 
humor and of K
+




-ATPase pump is an integral membrane 
protein expressed in the basolateral membrane of corneal endothelial cells that is responsible 
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for continuously pumping Na
+ 
out of the cell and K
+
 into the cell, utilizing the energy from 
ATP. Together with the movement of these ions, there is a passive flow of fluid from the 





-ATPase counteracts imbibition of water into the stroma, thus 
preventing stromal edema [1]. Meanwhile, ZO-1 is a part of submembranous cytoplasmic 
complex associated with tight junctions that form lateral interdigitated cell-to-cell junctions 
to act as barrier to bulk fluid flow from the aqueous humor [144]. As the presence of these 
two proteins is significant for proper functioning of the corneal endothelium, we chose them 





-ATPase and ZO-1 showed that HCEC-B4G12 on all patterns coated with different 




-ATPase was found 
throughout the cell surface with more localized expression at the cellular boundaries while 
ZO-1 was localized contiguously and formed interdigitation at cell-to-cell borders.  
From immunofluorescence staining images, especially from expression of ZO-1 and 
distribution of DAPI-stained nuclei, we could also observe the formation of confluent 
monolayer with uniformly distributed cells on FC- and LC-PDMS but not on FNC-PDMS. 
As our ECM staining indicated a thorough distribution of the coating despite the presence of 
occasional aggregates right before cell seeding, the formation of patches with open area on 
FNC-PDMS might have been caused by remodelling of the preadsorbed ECM proteins by the 
cells during culture, a process which is unique for each protein and cell type [145-147], 
resulting in areas that are devoid of the coating and thus not preferred by the cells.  
HCEC-B4G12 on different patterns coated with different ECM protein coatings also 




-ATPase and ZO-1, with highest 
expression of the two biomarkers on 1 µm pillar FC-PDMS and highest expression of ZO-1 
on 250 nm pillar LC-PDMS among their respective other patterns and unpatterned control. 
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The discrepancy in the results between RT-PCR and qPCR can be attributed to the difference 
in primer design and in the data collection between the two methods. Our primer sets for RT-
PCR were different from the ones recommended by Taqman® Gene Expression Assays for 
qPCR. Therefore, it is likely that the different primer sets have different affinity to bind DNA 
in the template priming regions as well as different ability to specifically and efficiently 
amplify the desired template fragments [148]. For future studies, it may thus be worthwhile to 
assess the possibility of using the same primer sets for the two experiments to reduce the 
discrepancy in the results. To understand the difference in the methods of data collection, an 
elaboration of how PCR works is presented as followed. PCR consists of 3 basic steps, 
namely strand denaturation, primer annealing, and primer extension. During the denaturation 
step, which occurs at 90-96 ºC, the strands of DNA helix unwound, resulting in single-
stranded DNA template. In the annealing step, the temperature is reduced to 50-60 ºC, 
allowing single-stranded DNA templates to hybridize with the primers at their 
complementary bases. In the extension step which generally takes place at 72 ºC, DNA 
synthesis occurs as the enzyme Taq polymerase copies the template strand using base pair 
complementarity. The three processes are repeated 25-30 times by cycling the temperature. 
Based on the amount of reagents present during these cycles, there are three amplification 
phases, namely exponential, linear, and plateau. The exponential phase occurs in the early 
cycles when the reagents are plenty and the PCR product is exactly doubled. As such, it is the 
most accurate phase to measure PCR products and provides the most accurate data for 
quantitation. During the linear phase, the availability of some of the reagents has become 
limited, leading to lowered PCR efficiency. In the last plateau phase, the reagents have 
become depleted and the reaction has stopped [149]. As qPCR measures PCR amplification 
at the exponential phase of the amplification, it is thus more accurate than RT-PCR which 
measures PCR products at the plateau phase. Since we used 35 cycles for RT-PCR, reducing 
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the number of cycle may result in lesser discrepancy and may warrant further investigation. 
In addition, RT-PCR results are based on size discrimination of the gel bands and therefore 
are qualitative and not very precise. Thus, we used qPCR as our main gene expression 
analysis and RT-PCR to check our finding. Protein expression analysis of both biomarkers in 
general also shows similar trends as that obtained from gene expression assay, indicating that 
the level of transcription among the cells on different patterns coated with different ECM 
protein coatings correlates with the level of translation, even though this correlation is not a 
must [150-151].  




-ATPase and ZO-1 marker expressions as the effect of 
topography coated with different biochemical cues, we next sought to examine alteration in 
cellular morphometry. Cellular morphometry, together with cell density, has been used as 
discard criteria for donor human corneal endothelium evaluation as tissue for transplant [152-
153]. It is also a clinically valuable parameter for evaluation post-operation such as 
keratoplasty and cataract surgery [154-157]. Thus, morphometric parameters are crucial in 
determining the feasibility of incorporating topography in the culture of human corneal 
endothelial cells for use in tissue engineering. As normal human corneal endothelial cells are 
mostly hexagonally shaped, one of the morphological characteristics that need to be 
examined in HCEC-B4G12 is the maintenance of this polygonal structure. Circularity 
measurement can be used to assess cell roundness with value of 1 indicating a perfect circle. 
On the other hand, low circularity value signifies that cells are elongated or spindle-like. 
Hence, HCEC-B4G12 having polygonal shape is expected to have circularity value that is 
close to 1 [62]. Our analysis indicates that HCEC-B4G12 on all combinations of pattern and 
ECM protein coating are highly circular with circularity value that is at least 0.77. The 
similar circularity value between unpatterned control and patterns indicates that HCEC-
B4G12 is already highly circular and that wells and pillars exerted only a subtle effect on cell 
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morphology. The minimal effect of well and pillar features on cell geometry had also been 
shown in other studies, including our previously published finding on BCEC in which 
circularity value on wells and pillars (approximately 0.5) was only slightly higher than that 
on the unpatterned control (0.47) [95, 101].  
Different from cellular morphology in which the effects of topography and ECM protein 
coating seemed minimal as indicated by similar circularity value, different patterns coated 
with different ECM protein coatings induced HCEC-B4G12 to have varying cell sizes. The 
higher cell area on FC-PDMS than on FNC- and LC-PDMS could be due to the higher initial 
attachment of the cells on FC-PDMS which subsequently led to better spreading and higher 
proliferation rate. Correlation between cell attachment and proliferation had also been 
reported in other studies with higher attachment leading to more spread appearance and 
higher proliferation rate [158-159]. The cells on FNC-PDMS may have also had similar cell 
area to that of FC-PDMS as they have comparable attachment and proliferation rate; 
however, due to the tendency of the cells to form patches with open areas on FNC-PDMS, the 
cells were forced to confine within smaller area, resulting in packed conformation with small 
cell area. This assumption may also explain the relation between the significantly high 
proliferation rate and low cell area on 1 µm pillar FNC-PDMS. On the other hand, due to the 
lower attachment and proliferation rate on LC-PDMS, the cells were moderately spread, 
resulting in an overall lower cell area than that on FC-PDMS. Adding to the overall 
difference in cell area on different ECM protein coatings, significant effect of topography 
within the same coating was apparent on 1 µm pillar FC-, FNC-, and LC-PDMS which 
induced substantially lower cell area than their respective other patterns and unpatterned 
control. 
CV of cell area indicates uniformity in cell area. Low CV value denotes homogenous cell 
area while high value suggests greater cell area variability. As the cells of the human corneal 
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endothelium in vivo exhibit regular area, low CV value in our cultured HCEC-B4G12 is 
desirable. While CV of cell area of HCEC-B4G12 on most combinations of pattern and 
protein coating was in the normal in vivo range, the lowest CV values were exhibited by cells 
on unpatterned FC-PDMS and 250 nm pillar LC-PDMS. 
By examining all our findings, we observed an overall enhanced HCEC-B4G12 behavior on 
1 µm pillar FC-PDMS and 250 nm pillar LC-PDMS. This improvement appears to be 
associated with lower cell proliferation rate on these two particular combinations of pattern 
and ECM protein coating in comparison to other patterns and unpatterned control of the 
respective coating. Although the reason remains to be elucidated, it might be that lower 
proliferation rate allows cells to have more interaction with substrate topography and enables 
cell maturation to play a bigger role in improving cellular behavior. In addition, the longer 
culture time on LC-PDMS than FC- and FNC-PDMS may have enabled nano-scaled 
topography to be sensed by the cells. Thus, for longer culture period, nano-sized pillar 
induces better HCEC-B4G12 cellular behavior than micro-sized pillar. On the other hand, for 
shorter culture period, cells may only be able to detect micro-sized pillar, rendering micro-
sized pillar more effective than nano-sized pillar in improving cellular morphometry and 
phenotype. Another finding that supports our postulate is given by HCEC-B4G12 on 
nanopillar FC-PDMS, on which the cells have high proliferation rate and undesirable 




-ATPase and ZO-1 gene and protein expression, lowest cell 
circularity, as well as highest cell area and CV of cell area. 
To summarize, our screening study of different ECM coatings indicates that FC and LC 
coatings were suitable for use in HCEC-B4G12 culture on PDMS while FNC coating was not 
recommended as the cells on the latter were not able to form confluent monolayer. 
Subsequently, we found that on FC-PDMS, 1 µm pillar resulted in cumulatively better 
HCEC-B4G12 behavior. The enhanced morphometry and phenotype are manifested in the 
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-ATPase and ZO-1 gene and protein expression as well as 
highest circularity and lowest cell area as compared to other patterns and unpatterned control. 
On LC-PDMS, HCEC-B4G12 showed improved cellular behaviors on 250 nm pillar with 
evidence of highest ZO-1 gene and protein expression and lowest CV of cell area among 





level among other LC-coated patterns although it is slightly lower than the unpatterned 
control. On the other hand, on FNC-PDMS, HCEC-B4G12 did not exhibit consistent trend in 
performance across all patterns tested which may be attributed to their inability to form 
uniform confluent monolayer, a feature critical for proper functioning of the corneal 
endothelium. In summary, our findings indicate that substrate topography modulates HCEC-
B4G12 behavior differently when different biochemical cues are used and interplay between 
specific combinations of these two factors can enhance cellular morphometry and phenotype. 
Consequently, the findings emphasize on the importance of selecting optimal culture 
conditions in order to yield better cellular outcome. In terms of application in corneal 
endothelial tissue engineering, depending on the coatings/ components constituting the 
cellular substrate and carrier, incorporating the respective optimal topography may result in 
enhanced and sustained cellular performance of the cell culture platform or tissue-engineered 
device for use in corneal regeneration and in vitro screening, testing, and development of 
ocular drugs. 
4. 2. Primary HCEC 
In this study, the limited availability of primary HCECs necessitates a careful preliminary 
selection of topographies and ECM protein coatings based on findings with HCEC-B4G12. 
As HCEC-B4G12 showed an overall better cellular behavior on 1 µm pillar FC-PDMS and 
250 nm pillar LC-PDMS, these topographies and ECM protein coatings were retained for our 
study with primary HCECs on PDMS. We found that long-term culture of primary HCECs 
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on PDMS did not help the cells to reach confluence. Instead, it resulted in cellular 
dedifferentiation to unknown cell type and reduction of cell number in most of the samples. 
In addition, F-actin staining conducted at the time point at which the cells appeared confluent 
and showed typical HCEC morphology revealed that cells on patterns were still relatively 
sparse. Our finding thus indicated that the current experimental set-up needs to be further 
optimized before study using PDMS as culture substrate could be resumed. 
Despite the inability to form confluent monolayer which is critical for the functioning of the 
endothelium, we observed the influence of topography on cell morphometry. While cell 
circularity was similar between patterns and the unpatterned control, cell area was lower on 
patterns in comparison to the unpatterned control on both FC- and LC-PDMS, indicating the 
potential of topography to regulate and improve cell morphometry. Cell area of cultured 
primary HCECs was on average 10 folds larger than that found in vivo, an observation similar 
to the study by Peh et al. in which cell sizes varied from approximately 750 µm
2
 to 5,400 
µm
2
, depending on the culture media used [83]. Thus, decreasing cell area becomes essential 
to obtain area as close to in vivo range as possible. Previously, studies have reported that 
substrate stiffness influences cell adhesion and spreading, among many aspects of cell 
function and morphology, in many types of cells [160-165]. Cell spreading area correlates 
strongly with the underlying substrate stiffness. In general, cells exert bigger traction force 
and exhibit larger, more stable adhesion and spreading with increasing substrate Young’s 
modulus. On the other hand, they are less contractile and have reduced adhesion strength on 
softer substrate (i.e. lower Young’s modulus) [162, 166-167]. As an example, fibroblasts in 
sparse cultures on polyacrylamide gel with stiffness of above 1 kPa were spread and 
exhibited fan-shaped form. When subjected to gel with stiffness of 100 Pa, however, they had 
a distinct rounded morphology [160]. The findings may explain the significantly larger 
primary HCEC cell spreading and thus cell area than that found in vivo in the study by Peh et 
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al. since TCPS, which has Young’s modulus three orders of magnitude larger than that of the 
Descemet’s membrane and hence is remarkably stiffer, was used as culture substrate. 
However, in our study we used PDMS with Young’s modulus that is approximately the same 
as that of the Descemet’s membrane. The physiologically relevant substrate stiffness in our 
study led us to expect the cells to exhibit a more typical HCEC behavior, including cell area 
comparable to in vivo value. The larger cell area observed in our study using PDMS substrate 
thus indicates that factors other than substrate stiffness and topography may play a bigger role 
in determining primary HCEC cell area. 









-ATPase on 250 nm pillar and 1 
µm pillar and its absence on the unpatterned control on LC-PDMS indicates phenotypic 
improvement by topography. Similarly, the higher density of ZO-1 on 250 nm pillar than on 
1 µm pillar and unpatterned control on LC-PDMS signifies positive influence of topography. 




-ATPase and ZO-1 on 1 µm pillar FC-PDMS 
suggests that this combination of pattern and ECM protein coating may lead to unfavourable 
phenotypic behavior of primary HCECs.  
ZO-1 staining on all combinations of pattern and ECM protein coating was mainly localized 
in the cytoplasm instead of at the cell borders, suggesting that primary HCECs on PDMS 
were unable to form proper cell-cell contact which appears to be due to large intercellular 
distance in the absence of confluent monolayer. 
To conclude, primary HCECs on PDMS substrate were not able to form confluent monolayer 
using the current experimental conditions. Nevertheless, we observed regulation of cellular 
morphometry and phenotype by the topographical and biochemical cues. On LC-PDMS, 
primary HCECs had cumulatively better cellular behavior on 250 nm pillar with cells having 
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-ATPase and ZO-1. On FC-PDMS, primary HCECs had better cellular 
morphometry on 1 µm pillar with significantly lower cell area than 250 nm pillar and the 





-ATPase and ZO-1 as compared to 250 nm pillar and the unpatterned 
control.  
The formation of denser fibrillar network of FC coating on TCPS than PDMS as shown by 
our SEM images may be caused by higher surface hydrophilicity of PDMS after plasma 
treatment. While the inherent hydrophobic nature of PDMS surface is good for protein 
adsorption [168], plasma treatment is necessary to increase the wettability of surface and thus 
improve cell adhesion suspended in water-based medium. The difference in the protein 
coating adsorption rate between TCPS and PDMS albeit under the same treatment condition 
indicates that the two materials react differently to plasma treatment. However, the difference 
in the exact nature of the two materials in relation to plasma treatment is unclear and may 
warrant further research.  
The higher replication fidelity of 250 nm pillar TCPS as compared to 250 nm pillar PDMS 
could be attributed to the different master templates used. A 250 nm well silicon master mold 
was used to generate an inverse replica of the master (i.e. 250 nm pillar) in PDMS samples. 
For fabricating 250 nm pillar TCPS, a 250 nm pillar polycarbonate master was used to 
produce an inverse replica (i.e. 250 nm well) in PDMS stamp which was then used to heat 
emboss 250 nm pillar in TCPS samples. Although it was possible to directly heat emboss 250 
nm pillar TCPS samples using 250 nm well silicon master, we did not use that method as the 
master would have a limited reusability (<5 in several cases) due to cracking and warping 
from high temperature and stress cycles incurred in embossing [169]. The use of PDMS 
stamp for heat embossing allows for relatively inexpensive and faster production of TCPS 
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samples due to its ability to withstand higher embossing cycles as well as easier and less 
expensive fabrication. Similarly, while it was possible to generate 250 nm pillar PDMS 
samples by double casting using 250 nm pillar polycarbonate master, casting PDMS over 
PDMS was challenging due to strong bonding between the two layers which consequently 
impeded demolding and increasing detachment force that may deteriorate the replicated 
pattern [132, 134, 169-170]. While silanization could prevent the strong adhesive interaction 
and thus enable easy release of sample from the stamp [132, 134, 171-172], this elaborate 
approach that involved adsorbed layer of fluorinated groups on the surface may detrimentally 
alter the structure of the nano-sized feature on PDMS [173]. Nonetheless, the adhesion 
problem may be solved using a composite stamp of PDMS and hard PDMS (h-PDMS). h-
PDMS has a higher Young’s modulus than the normal PDMS and can be coated as a thin 
layer on the PDMS. The composite stamp has been shown to transfer nano-sized structure 
with high fidelity [103, 128-129, 174] and hence may worth further investigation. 
Our preliminary results indicate that primary HCECs were able to form confluent monolayer 
with ZO-1 expression localized at cell-to-cell borders when the culture substrate was 
substituted to TCPS. In parallel with the previous discussion regarding substrate stiffness and 
cell spreading, the formation of confluent monolayer and larger cell area by primary HCECs 
on TCPS than on PDMS may be due to the better spreading of the cells on this stiffer 
substrate. Proliferation assay signifies that cell growth is differently modulated in different 
media with higher overall growth rate in proliferation medium than in maintenance medium. 
In addition, cell morphometry is differently regulated on different combinations of pattern 
and protein coating. As primary HCECs in vitro are slowly proliferative, finding specific 
combinations of topography and ECM protein coating that can enhance cell proliferation 
while maintaining physiological cell morphometry and phenotype is highly desirable. 
Maintenance medium is observed to preserve the normal morphology of primary cells but 
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minimally support cell growth (personal communication with G. Peh and J. Mehta, 2012) 
while proliferation medium supports the proliferation of primary cells but without retaining 
morphological integrity of polygonal cell shape [83]. Our findings that in maintenance 
medium, primary HCECs on 1 µm well FNC-TCPS had the highest proliferation rate with 
comparable cell circularity and lowest cell area among other pattern and unpatterned control, 
as well as lower CV of cell area than the unpatterned control may indicate the potential of 
this combination of pattern and protein coating to improve primary HCEC behavior. 
However, further studies are needed to deduct a more thorough conclusion as to what other 
topographies coated with different ECM protein coatings regulate and improve morphometry 
and phenotype of primary cells on TCPS. As our preliminary characterization study was 
conducted in maintenance medium, it would also be interesting to investigate if topography 
and protein coating were able to improve cell morphometry and phenotype in proliferation 
medium.   
4. 3. Future Studies  
In general, the observed difference in cellular behaviors of both HCEC-B4G12 and primary 
HCEC on different patterns coated with different ECM coatings elicits an interest in how this 
difference occurs. As the study presented in this thesis focuses on the cellular outcome/ end 
results and the potential utility of cultured HCEC in tissue engineering of corneal tissue, 
evaluation and determination of ECM protein coating deposition on the patterns as well as 
mechanism of cellular adhesion and interaction with ECM-coated topography will give a 
better understanding of how cells transduced the information received from extracellular 
environment into an intracellular event. These characterizations will also enable isolation of 
the effects of topography from ECM protein coating. Some characterizations of preadsorbed 
ECM deposition include contact angle measurement [175-176], fluorescence imaging [177-
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178], and transmission electron microscopy (TEM) [179-180]. While fluorescence imaging 
and TEM allow for direct visualization of the deposited ECM, contact angle measures surface 
tension and wettability which give an indirect indication of the presence and degree of ECM 
deposition. The reduction in contact angle after ECM protein coating indicates that the 
coating is deposited on the surface, rendering it more hydrophilic [181]. Cellular contact with 
topography can be investigated with visualization of focal adhesion localization [182-183], 
cellular adhesion processes can be monitored in real time using quartz crystal microbalance 
with dissipation monitoring [145, 184-185], and cellular interaction with ECM protein 
coating can be studied with fluorescence imaging of ECM receptors [186-187]. Combined 
with fluorescence imaging, the dynamic of cellular interaction and remodeling of ECM 
protein coating can be performed using differential interference contrast microscopy, 
confocal reflection microscopy, optical coherence tomography, multiphoton microscopy, and 
second-harmonic generation imaging [188]. 
For HCEC-B4G12, future studies also include functionality testing as gene and protein 
expression of functional biomarkers does not guarantee functional performance. Pump 




-ATPase assay to investigate if the gene and protein 
expression correspond to functional activity. There are two simple methods to measure the 
activity of the pump protein, namely the Fiske-Subbarow method and the Baginski method 
[189]. Both methods are based on the measurement of liberated inorganic phosphate as a 
product of ouabain-sensitive hydrolysis of ATP by the pump protein. Ouabain is one of 
cardiotonic derivatives which are widely prescribed inhibitors for patients with heart failure 




-ATPase and inhibits its activity, 






 exchanger, which exchanges 1 intracellular 
Ca
2+ 
for 3 extracellular Na
+
, is inhibited due to the increased intracellular Na
+
. This 
subsequently results in increase of intracellular Ca
2+
 which when triggered, allows for greater 
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calcium release and thus increase in the force of myocardial contraction [191]. The inclusion 
of ouabain in the pump activity measurement thus serves as a reagent blank and a blank for 
nonspecific ATPase activity. The amount of inorganic phosphate produced by the pump 
activity is estimated from calibration curve of an inorganic phosphate standard after 
normalizing the absorbance reading against H2O blank and subtracting from ouabain-treated 
sample prepared in parallel.   
The working of ion transport systems and the integrity of tight junctions of the corneal 
endothelial monolayer can be investigated with transepithelial electrical resistance (TER) 
measurement. There are two systems that are commonly used to measure TER, namely 
Ussing chamber and resistance meter [192]. Ussing chamber provides a physiological system 
to precisely measure active transport of ions, nutrients, and drugs across an intact cell layer 
[193]. It also validates the integrity of the tight junction and thus maintenance of apical and 
basolateral membrane polarity. The basic operation principles of Ussing chamber are briefly 
described as followed: the membrane to be tested is mounted vertically to separate two halves 
of the chamber, each of which superfuses the membrane with equal volume of identical 
electrolyte solution. The identical composition and volume of the bathing solution annihilate 
paracellular ion movements induced by passive forces of transmembrane concentration as 
well as osmotic and hydrostatic gradients. The passive transmembrane diffusion force caused 
by spontaneous electrical potential is eliminated by clamping the potential to zero. Thus, 
movements of ions and nutrients as measured by the short-circuit current are a result of active 
transport. To maintain the physiological environment in the chamber, the reservoirs above the 
chamber are water-jacketed to warm the superfusate, which is typically a CO2/HCO3
−
-
buffered Ringer solution, to body temperature. Oxygen and carbon dioxide composition of 
the physiological buffer are maintained by injection ports and normally consists of 95% 
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O2 and 5% CO2. This particular gas composition, termed carbogen, also sustains the buffer at 
physiological pH of 7.4.  
Resistance meter, on the other hand, measures TER of cells cultured in inserts [192]. The 
resistance is measured by applying an AC square wave current with a silver electrode and 
measuring voltage deflection elicited with a pair of silver/silver-chloride wire electrode, one 
on each side of the insert cylinder. The leads from the electrodes are directly connected to a 
measurement device such as Epithelial Voltohmmeter (EVOM) or Electrical Resistance 
System (ERS). AC square wave avoids adverse effects on tissues and its uniform density 
minimizes errors due to electrode polarization and membrane capacitance. TER of the sample 
is obtained after subtracting the contribution of bathing and filter solution. Leaky barrier and 
thus high permeability will yield low electrical resistance while tight barrier will result in 
high resistance.  
For primary cells, as our current experimental set-up does not induce formation of confluent 
monolayer on PDMS, further optimization is needed before research into the effects of 
topography patterned onto PDMS substrate could be resumed. Some of the parameters that 
can be manipulated include the concentration and incubation period of the ECM protein 
coatings, the cell seeding density, and the compositions of the culture medium. On the other 
hand, if TCPS were to be used as culture substrate instead of PDMS, as our preliminary 
results with TCPS indicate that primary cells were able to form confluent monolayer, studies 
to validate the results presented in this study such as those that had been conducted and 
proposed as future studies for HCEC-B4G12 on PDMS could be performed. The results from 
those studies will then reveal the effects of topography and ECM protein coating on primary 
HCEC and if any combinations could lead to an overall enhanced cell behavior. 
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Lastly, as ECM in vivo is a highly complex structure consisting of a wide variety of structural 
and functional proteins, glycoproteins, and proteoglycans [117], only the complete isolation 
of an ECM can provide the needed signals for cellular instructions in the same ratios, 
conformations, and spatial orientations as those found in their native environment [194]. 
Thus, the incorporation of only several ECM components in our study can only limitedly 
emulate native extracellular biochemical microenvironment. In addition, the methods of ECM 
extraction and purification in commercial ECM products had raised the issue of whether the 
relatively fragile and sensitive ECM proteins had undergone alteration in their structure, 
function, and bioactivity [194-195]. Nevertheless, as the complex organization of structural 
and functional molecules that compose the ECM has not been fully characterized and 
understood [195], its synthesis in the laboratory is not yet possible and hence the selection of 
relevant ECM components for our study is justified. Future studies may thus include a more 
complete and defined ECM components to enhance and sustain cell behaviors in vitro that 
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